Created_at,Tweet_Words,Score
2020-04-09 21:42:26+00:00,burke herbert bank trust grows,0.6405636072158813
2020-04-09 17:02:25+00:00,hexavest million position,0.242339625954628
2020-04-09 13:32:27+00:00,,0.5180692672729492
2020-04-09 13:04:34+00:00,embedded expectations analysis usa currently corporate averages relative uniform earnings uniform levels equity,-0.8025517463684082
2020-04-09 12:07:37+00:00,uptrend moving average divergence macd crosses signal line view odds money news,0.9489938020706176
2020-04-09 07:06:24+00:00,adviser llc raises position,0.4072374403476715
2020-04-09 05:58:39+00:00,pembrolizumab receives us fda priority review patients tumour mutuation burden regardless tumour type,0.4462927877902984
2020-04-09 00:30:45+00:00,latest oncology update,0.2208184748888015
2020-04-10 22:31:12+00:00,peak profit expired,0.2009282559156417
2020-04-10 22:23:04+00:00,peaked triggered algo,0.919970154762268
2020-04-10 22:19:01+00:00,view historical performance,0.0985150188207626
2020-04-10 18:42:30+00:00,uncommon cents,-1.0291588306427002
2020-04-10 18:17:30+00:00,acquired cypress wealth services,0.3651784360408783
2020-04-10 17:02:30+00:00,carroll financial million,0.1196251884102821
2020-04-10 16:07:30+00:00,mission wealth management lp,-0.8118768930435181
2020-04-10 11:07:24+00:00,uptrend moving average divergence macd turned positive view odds money news,0.960663914680481
2020-04-10 11:07:02+00:00,given consensus rating brokerages,0.8550620079040527
2020-04-10 11:06:11+00:00,brokerages set target,0.0958971008658409
2020-04-10 11:05:29+00:00,brokerages set target,0.0958971008658409
2020-04-11 13:03:38+00:00,app,0.1562585085630417
2020-04-11 12:05:02+00:00,recommendation ub rating,-0.1933444291353225
2020-04-11 12:04:01+00:00,explore fundamental numbers pros cons,-0.2624247074127197
2020-04-11 11:31:13+00:00,upcoming event vaccines expiring cover event implied move,0.2294777333736419
2020-04-11 10:57:39+00:00,wealthtrust axiom,-0.7598159313201904
2020-04-11 10:20:41+00:00,uptrend moving average divergence macd turned positive view odds money news,0.960663914680481
2020-04-11 07:06:24+00:00,alpha cubed llc,0.2398673444986343
2020-04-12 22:26:31+00:00,wealth advisors lowers stake,-0.4029102623462677
2020-04-12 21:52:42+00:00,receives average recommendation analysts,0.84912109375
2020-04-12 21:51:53+00:00,given average rating brokerages,0.8412586450576782
2020-04-12 12:45:08+00:00,informative app pivot points close pivot point download tradingview stockstowatch,0.8902355432510376
2020-04-12 10:02:48+00:00,churchill management corp,-0.8807568550109863
2020-04-12 08:37:43+00:00,uptrend moving average divergence macd turned positive view odds money news,0.960663914680481
2020-04-12 05:37:48+00:00,gillespie robinson grimm acquires,0.2287644743919372
2020-04-13 23:31:35+00:00,jacobs boosts stake,0.2649970352649688
2020-04-13 20:01:34+00:00,mm practice,-0.2823741436004638
2020-04-13 18:43:03+00:00,latest update oncology,0.3583715856075287
2020-04-13 17:34:49+00:00,endometriosis pain gefapixant shows clincally rmeaningful signal huge gnrh agonists problematic due mechanism osteoporosis risk antagonists equally worrisome,-0.9509284496307372
2020-04-13 15:25:10+00:00,target cut analysts ubs,-1.0126184225082395
2020-04-13 14:53:06+00:00,target cut analysts ubs,-0.9554266929626464
2020-04-13 14:52:19+00:00,target cut analysts ubs,-0.9554266929626464
2020-04-13 14:51:12+00:00,pt lowered ubs,-0.9357736110687256
2020-04-13 14:50:36+00:00,showing depressed medium rank relative higher outlook,-1.0732465982437134
2020-04-13 13:00:23+00:00,pdufa date calendar,0.1528167426586151
2020-04-13 11:45:07+00:00,astrazeneca azn announce koselugo approved fda pediatric patients older nf,0.2085656374692917
2020-04-13 11:29:52+00:00,koselugo registered selumetinib approved fda pediatric patients older neurofibromatosis type,0.2282748371362686
2020-04-13 11:20:38+00:00,apr straddle implies move apr vaccines,0.2590605616569519
2020-04-13 11:09:15+00:00,astrazeneca azn announce koselugo approved fda pediatric patients older symptomatic inoperable pn,0.2021813541650772
2020-04-13 10:59:35+00:00,latest update oncology,0.2962027788162231
2020-04-13 10:56:35+00:00,koselugo registered approved fda pediatric patients older neurofibromatosis type symptomatic inoperable plexiform,0.1848265826702118
2020-04-13 10:15:17+00:00,pt lowered ubs,-1.030652403831482
2020-04-13 09:55:03+00:00,directional bias report click details,-0.7779198884963989
2020-04-13 09:52:20+00:00,report click,0.2802823483943939
2020-04-13 09:44:00+00:00,uptrend moving average divergence macd turned positive view odds money news,0.960663914680481
2020-04-13 09:29:46+00:00,rexahnpharmaceuticals terminates breast cancer study,-0.6052781343460083
2020-04-13 03:01:34+00:00,sanders morris harris,-0.5278066396713257
2020-04-14 23:36:36+00:00,purchased stolper,0.2374571561813354
2020-04-14 23:01:36+00:00,salem capital management,-0.7794661521911621
2020-04-14 21:16:46+00:00,almost ready,0.7500708103179932
2020-04-14 19:38:35+00:00,hump,-0.0541131645441055
2020-04-14 18:26:17+00:00,flirting resistance heavy eyes gang,-0.9960793256759644
2020-04-14 17:52:31+00:00,deeper wider moat cancer treatments way,0.1743606626987457
2020-04-14 17:38:50+00:00,fallen well forward climbing someday glta,0.9656447172164916
2020-04-14 14:26:30+00:00,recent technical upper bollinger band walk,0.0150048844516277
2020-04-14 12:21:29+00:00,sprifermin increases cartilage thickness reduces loss knee oa,-0.5416650772094727
2020-04-14 11:24:23+00:00,uptrend moving average divergence macd crosses signal line view odds money news,0.9489938020706176
2020-04-14 10:11:22+00:00,sentiment total scores positive negative sentiment,-0.0440361015498638
2020-04-14 09:03:11+00:00,target lowered ubs,-0.9270496368408204
2020-04-14 09:00:46+00:00,target lowered ubs,-0.9270496368408204
2020-04-14 09:00:17+00:00,target lowered ubs,-0.9270496368408204
2020-04-14 08:59:58+00:00,target lowered ubs,-0.9270496368408204
2020-04-14 04:46:36+00:00,truewealth lowers position,-0.5985605716705322
2020-04-14 04:31:20+00:00,oversold imo,-0.8839130401611328
2020-04-14 04:11:36+00:00,howland capital management,-0.7166825532913208
2020-04-14 03:31:36+00:00,deprince race zollo increases stake,0.799537181854248
2020-04-14 02:56:36+00:00,louisiana state employees retirement million position,0.1233606040477752
2020-04-14 00:06:21+00:00,honorable mentions cdc bush cdc director came play role clade tx czars roy vagelos step aside ra arch,0.8146466016769409
2020-04-15 21:27:44+00:00,launches herceptin biosimilar named ontruzant listed discount branded drug,0.1832518875598907
2020-04-15 21:14:08+00:00,zacks brokerages expect announce earnings,0.281205415725708
2020-04-15 21:13:45+00:00,zacks brokerages expect announce earnings,0.281205415725708
2020-04-15 21:13:00+00:00,zacks brokerages expect announce earnings,0.3684892654418945
2020-04-15 17:06:36+00:00,raised baldwin brothers,0.5370640754699707
2020-04-15 17:03:04+00:00,long true,0.8702493906021118
2020-04-15 16:19:48+00:00,learn latest oncology news,0.3423519730567932
2020-04-15 15:48:34+00:00,gefapixant em yr done recruitment guidance,-0.0862189829349517
2020-04-15 15:47:58+00:00,waiting turn around change recently,0.174022227525711
2020-04-15 15:45:49+00:00,action,0.7652591466903687
2020-04-15 15:45:42+00:00,announces us launch ontruzant biosimilar herceptin ontruzant list vial,0.1574045419692993
2020-04-15 15:39:27+00:00,big pharma tick,0.0088699720799922
2020-04-15 15:36:54+00:00,big pharma tick economy,0.0201359316706657
2020-04-15 14:59:44+00:00,hair dresser,0.1051445081830024
2020-04-15 14:53:20+00:00,history tends repeat report,0.6846514940261841
2020-04-15 14:48:46+00:00,imo drop pick dip,-1.0647900104522705
2020-04-15 14:35:37+00:00,samsung bioepis launching herceptin biosimilar discount brand wac,0.1657551676034927
2020-04-15 11:51:19+00:00,sentiment total scores positive negative sentiment,-0.0431540682911872
2020-04-15 11:49:36+00:00,eps estimates lowered svb leerink,-0.8594070672988892
2020-04-15 11:45:15+00:00,eps estimates lowered svb leerink,-0.8594070672988892
2020-04-15 11:45:09+00:00,eps estimates lowered svb leerink,-0.9525419473648072
2020-04-15 11:13:09+00:00,announces us launch ontruzant registered biosimilar herceptin registered trastuzumab,0.1133704483509063
2020-04-15 11:12:26+00:00,announces us launch ontruzant registered biosimilar herceptin registered trastuzumab,0.1133704483509063
2020-04-15 11:12:11+00:00,action,0.7413638830184937
2020-04-15 11:06:36+00:00,launches herceptin biosimilar,0.0748028010129928
2020-04-15 10:49:46+00:00,announces us launch ontruzant biosimilar herceptin ontruzant list vial vial,0.1708765923976898
2020-04-15 10:49:32+00:00,learn latest oncology news,0.30426687002182
2020-04-15 09:09:04+00:00,ubs lowers target,-0.4892232120037079
2020-04-15 09:08:52+00:00,ubs lowers target,-0.4892232120037079
2020-04-15 09:07:49+00:00,ubs lowers target,-0.4892232120037079
2020-04-15 09:06:37+00:00,ubs lowers target,-0.7092818021774292
2020-04-15 09:05:38+00:00,ubs lowers target,-0.4892232120037079
2020-04-15 08:50:44+00:00,moving average moved moving average view odds money news,0.9106823205947876
2020-04-15 00:46:36+00:00,cra financial services grows position,0.6485590934753418
2020-04-15 00:41:36+00:00,hennessy advisors increases position,0.8852276802062988
2020-04-15 00:21:36+00:00,shilanski,-0.7235465049743652
2020-04-15 00:06:36+00:00,asset management corp il adv,-0.7318311929702759
2020-04-16 22:21:38+00:00,ballast advisors,0.1287561058998108
2020-04-16 19:10:09+00:00,informative app pivot points close pivot point download tradingview stockstowatch,0.8716952800750732
2020-04-16 15:44:10+00:00,triggering slow mover long term,0.9090304374694824
2020-04-16 14:50:11+00:00,,0.9318573474884032
2020-04-16 14:28:24+00:00,earnings svb leerink forecasts,0.4925800561904907
2020-04-16 14:27:59+00:00,earnings svb leerink forecasts,0.3582043945789337
2020-04-16 13:48:04+00:00,delta expiration,-0.0167825557291507
2020-04-16 09:36:42+00:00,uptrend jump broke lower bollinger band view odds money news,0.940142035484314
2020-04-16 07:54:55+00:00,announces us launch ontruzant registered biosimilar herceptin registered trastuzumab,0.0276568233966827
2020-04-16 05:41:36+00:00,expected earnings,0.3858420252799988
2020-04-16 05:39:09+00:00,expected earnings,0.3858420252799988
2020-04-16 05:37:36+00:00,expected earnings,0.3858420252799988
2020-04-16 02:52:00+00:00,launches latest herceptin knockoff harvard spinout grabs seed round,0.3465863764286041
2020-04-16 02:31:36+00:00,zacks brokerages expect announce earnings,0.4000797569751739
2020-04-17 23:58:37+00:00,corporate interesting fridayreads stayhomestayupdated,0.9727075099945068
2020-04-17 21:11:39+00:00,bought nwam,0.7494176626205444
2020-04-17 19:37:45+00:00,order flow sentiment turned bearish bullish,-0.9003134965896606
2020-04-17 19:34:45+00:00,winner lucky winner,0.9624741077423096
2020-04-17 19:24:53+00:00,guess close,-0.0917158722877502
2020-04-17 14:10:50+00:00,fundamental reasons,-0.7355860471725464
2020-04-17 13:10:32+00:00,hanging around thoughts direction,0.849494218826294
2020-04-17 11:07:30+00:00,forecasted earnings,0.385406881570816
2020-04-17 11:06:52+00:00,expected earn earnings,0.3290565013885498
2020-04-17 11:04:58+00:00,forecasted earnings,0.385406881570816
2020-04-17 11:04:26+00:00,earnings svb leerink forecasts,0.3361362814903259
2020-04-17 09:14:23+00:00,zacks brokerages expect announce sales billion,0.0640686005353927
2020-04-17 09:04:12+00:00,moving average crossed moving average view odds money news,0.8968733549118042
2020-04-17 08:40:03+00:00,zacks brokerages anticipate announce sales billion,0.0831973031163215
2020-04-17 08:39:00+00:00,zacks brokerages anticipate announce sales billion,0.0831973031163215
2020-04-17 03:22:43+00:00,ended gaining current marketcap current dividend yield earnings opens wallstreet estimate mean estimate low estimate investingnews,0.8157176971435547
2020-04-18 23:21:04+00:00,phase immunobridging study valent human papillomavirus vaccine chinese females,-0.0189870558679103
2020-04-18 23:15:31+00:00,phase phase combination avelumab advanced cell lung cancer nct estimated,0.2930653989315033
2020-04-18 23:15:26+00:00,phase bioequivalence study coated cesol tablet formulation versus biltricide nct estimated primary compl,-0.0290934592485427
2020-04-18 23:08:32+00:00,gs frequently conversations sense growing appreciation risk company guidance particularly china gardasil animal health covid debate potential impact magnitude keytruda,-1.0394036769866943
2020-04-18 15:24:55+00:00,phase immunobridging study valent human papillomavirus vaccine chinese females age nct estimated primary completion date,-0.0170655399560928
2020-04-18 15:23:58+00:00,phase phase combination avelumab advanced cell lung cancer nct estimated primary completion date,0.5006834268569946
2020-04-18 15:23:02+00:00,phase bioequivalence study coated cesol tablet formulation versus biltricide nct estimated primary completion date,-0.0220033638179302
2020-04-18 11:21:41+00:00,zacks analysts anticipate earnings,0.2660569846630096
2020-04-18 11:17:18+00:00,rejection strength demark setup perfection trigger triggered cros,0.2689613997936249
2020-04-18 11:00:20+00:00,zacks analysts anticipate earnings,0.2660569846630096
2020-04-18 10:49:01+00:00,unicorn bay rating,0.3294529616832733
2020-04-18 10:32:02+00:00,recommendation ub rating,-0.1215898618102073
2020-04-18 09:05:21+00:00,technical dma resistance pocket pivot,-0.0668964684009552
2020-04-18 09:01:10+00:00,uptrend moving average divergence macd crosses signal line view odds money news,0.9489938020706176
2020-04-18 08:21:40+00:00,eps estimates boosted analyst,0.812620997428894
2020-04-18 08:07:48+00:00,eps estimates boosted analyst,0.7111498117446899
2020-04-18 08:04:32+00:00,eps estimates boosted analyst,0.7111498117446899
2020-04-18 08:03:51+00:00,eps estimates boosted analyst,0.7111498117446899
2020-04-18 06:31:03+00:00,rejection strength demark setup perfection trigger triggered crossovers stockstowatch optionsscalping,0.9284861087799072
2020-04-19 19:00:38+00:00,uptrend moving average divergence macd crosses signal line view odds money news,0.9489938020706176
2020-04-19 17:51:52+00:00,single point partners acquires,0.2390948683023452
2020-04-19 15:11:52+00:00,welch forbes grows stake,0.2869513034820556
2020-04-19 12:31:52+00:00,pinnacle financial partners,0.251966655254364
2020-04-19 09:00:11+00:00,peak profit expired,0.5009063482284546
2020-04-19 08:56:08+00:00,apr,0.8734750747680664
2020-04-19 08:48:07+00:00,peaked triggered algo,0.923141598701477
2020-04-19 08:44:05+00:00,view historical performance,0.0985150188207626
2020-04-19 05:34:48+00:00,gs frequently conversations sense growing appreciation risk,-1.0227656364440918
2020-04-19 03:56:35+00:00,implied volatility expiration,-1.0676428079605105
2020-04-19 02:41:44+00:00,ifg advisors purchases,0.1835841089487075
2020-04-20 23:16:59+00:00,northstar asset management raises,0.5948518514633179
2020-04-20 23:07:00+00:00,jan sweep near ask oi earnings open ref sweeps ask,0.355149894952774
2020-04-20 22:26:09+00:00,billion us pharmaceutical company dddd clinical dddd thera,0.155029147863388
2020-04-20 21:10:47+00:00,billion us pharmaceutical company dddd clinical dddd therapeutic combination keytruda signed vaccine deal dddd,0.392354279756546
2020-04-20 19:42:51+00:00,set hook,0.7747666835784912
2020-04-20 18:48:35+00:00,toes water,0.4956548810005188
2020-04-20 18:46:41+00:00,beat pan steady gl,0.9866535663604736
2020-04-20 18:36:11+00:00,smooth,0.947547435760498
2020-04-20 16:53:46+00:00,million dark pool print bought,-0.0672242939472198
2020-04-20 16:51:00+00:00,million dark pool print bought,0.1855551898479461
2020-04-20 15:12:37+00:00,performing change recently,0.1855906993150711
2020-04-20 14:59:42+00:00,notes adding pharma growth however earnings multiples,0.8095462322235107
2020-04-20 14:59:41+00:00,low earnings ratios bill alpert writes edition barron lagging behind eli lilly lly outperformed index coronavirus disruption began author,-1.0291703939437866
2020-04-20 13:39:00+00:00,phase checkpoint inhibitor dlbcl nct estimated primary completion date,-0.0461990796029567
2020-04-20 13:38:02+00:00,phase study pembrolizumab maintenance platinum based chemotherapy patients metastatic squamous cell lung cancer snsclc nct estimated primary completion date,0.0560216382145881
2020-04-20 13:37:04+00:00,phase pembrolizumab chemoradiation treatment advanced cervical cancer nct estimated primary completion date,0.5309668779373169
2020-04-20 13:36:07+00:00,phase neoadjuvant pembrolizumab pbr pbr epirubicin cyclophosphamide tnbc nct estimated primary completion date,-0.0166521742939949
2020-04-20 13:35:09+00:00,phase comparative study determine efficacy safety tolerability nct estimated primary completion date,0.2153631299734115
2020-04-20 13:34:11+00:00,phase valent hpv vaccine anal dysplasia nct estimated primary completion date,0.3138936460018158
2020-04-20 13:33:13+00:00,phase study pembrolizumab without combination chemotherapy versus chemotherapy alone urothelial carcinoma mk keynote nct estimated primary completion date,-0.0148159451782703
2020-04-20 12:39:59+00:00,real crowd pleasure glta,0.9910995960235596
2020-04-20 12:27:26+00:00,gathering revenue reporting tear earnings,0.9413005113601683
2020-04-20 10:31:22+00:00,uptrend moving average divergence macd crosses signal line view odds money news,0.9489938020706176
2020-04-20 09:32:48+00:00,peak profit expired,0.5009063482284546
2020-04-20 09:20:45+00:00,peaked triggered algo,0.923141598701477
2020-04-20 09:16:43+00:00,view historical performance,0.0985150188207626
2020-04-20 02:29:19+00:00,darmstadt germany awarded second patent crispr technology,-0.0162564516067504
2020-04-20 02:27:28+00:00,darmstadt germany awarded second patent crispr technology,-0.0263014510273933
2020-04-21 21:57:03+00:00,sumitomo mitsui ds asset management company ltd grows position,0.6065719127655029
2020-04-21 21:31:20+00:00,nominates risa health health equity university pennsylvania board corpgov,0.0249946117401123
2020-04-21 21:31:00+00:00,hardly came air deviation band constant resistance continued drive lower,-1.0675429105758667
2020-04-21 21:29:34+00:00,thought saving lives,0.7232422828674316
2020-04-21 21:28:58+00:00,mer ck kgaa opening gene ther py vi ral vec tor fac ry carls bad bigpharma,-1.0165759325027466
2020-04-21 21:25:06+00:00,sector stink picked turn triple dividend,-1.0301417112350464
2020-04-21 20:17:25+00:00,crashes closing lower sentiment bearish,-1.0825109481811523
2020-04-21 17:57:02+00:00,boston trust walden corp decreases stake,-0.8706814050674438
2020-04-21 17:50:02+00:00,,-0.9444359540939332
2020-04-21 16:59:01+00:00,idorsia rival insomnia drug clears phase test daridorexant compete insomnia drug,-0.0642591565847396
2020-04-21 16:37:02+00:00,baugh,-0.7123727798461914
2020-04-21 11:52:56+00:00,expands program amid pandemic disruptions,0.0439393222332
2020-04-21 11:45:49+00:00,expands program amid pandemic disruptions,-0.0096569769084453
2020-04-21 11:42:00+00:00,expands program amid pandemic disruptions,0.0051764920353889
2020-04-21 11:21:15+00:00,phase study pembrolizumab without combination chemotherapy versus chemotherapy alone ur,0.0212846212089061
2020-04-21 11:21:12+00:00,phase valent hpv vaccine anal dysplasia nct estimated primary completion date,0.6102234125137329
2020-04-21 11:20:44+00:00,phase neoadjuvant pembrolizumab pbr pbr epirubicin cyclophosphamide tnbc nct,-0.0115571841597557
2020-04-21 11:20:41+00:00,phase pembrolizumab chemoradiation treatment advanced cervical cancer nct estimated primary complet,0.8162316083908081
2020-04-21 11:20:38+00:00,phase study pembrolizumab maintenance platinum based chemotherapy patients metastati,0.2939337790012359
2020-04-21 11:20:36+00:00,phase checkpoint inhibitor dlbcl nct estimated primary completion date,-0.045473176985979
2020-04-21 11:07:35+00:00,broadens patient assistance programs part overall covid relief efforts,0.90962016582489
2020-04-21 11:06:52+00:00,broadens patient assistance programs part overall covid relief efforts,0.9312857389450072
2020-04-21 10:56:33+00:00,broadens patient assistance programs part overall covid relief efforts,0.931719183921814
2020-04-21 09:27:35+00:00,uptrend moving average divergence macd crosses signal line view odds money news,0.9489938020706176
2020-04-21 05:13:12+00:00,set announce earnings,0.0443972796201705
2020-04-21 05:12:13+00:00,set announce earnings,0.0443972796201705
2020-04-21 05:11:32+00:00,set announce earnings,0.0547903627157211
2020-04-21 05:09:50+00:00,set announce earnings,0.0443972796201705
2020-04-21 03:04:17+00:00,expected earnings,0.3585638999938965
2020-04-21 01:49:34+00:00,zacks analysts expect announce sales billion,0.0867851376533508
2020-04-22 22:32:03+00:00,peak profit expired,0.5009063482284546
2020-04-22 22:24:00+00:00,peaked triggered algo,0.923141598701477
2020-04-22 22:19:57+00:00,view historical performance,0.0985150188207626
2020-04-22 21:47:14+00:00,founders capital management lowers stake,-0.3906145393848419
2020-04-22 19:25:17+00:00,hay wall street bs unbelievable reap stink unfair bots need shut,-1.074281930923462
2020-04-22 17:47:12+00:00,oliver luxxe assets million stake,0.2310172617435455
2020-04-22 16:24:58+00:00,wear mask,-0.0592123493552207
2020-04-22 16:20:18+00:00,honey hole ask,0.1723738610744476
2020-04-22 16:03:58+00:00,paydirt ran thru money maker washed gold nuggets batch,0.3744752705097198
2020-04-22 15:50:37+00:00,stalled lets hole,-0.3508122563362121
2020-04-22 15:42:18+00:00,hump treats eye eye,0.1126637607812881
2020-04-22 15:27:59+00:00,bull ox ox ox corner imo,-0.0266984142363071
2020-04-22 15:20:53+00:00,imo pull foolish powered mms usual helps big boys billions smart understand shows glta,0.9371192455291748
2020-04-22 14:57:53+00:00,reason track pps mm elgro bots us slide together earnings dip trick,0.9511021375656128
2020-04-22 13:58:36+00:00,certainly data based cautiousness exhibited,0.9560370445251464
2020-04-22 04:17:12+00:00,west branch capital,-0.7982439994812012
2020-04-23 22:33:44+00:00,closely rips change recently,0.264119416475296
2020-04-23 21:50:04+00:00,directional bias report click details,-0.7779198884963989
2020-04-23 21:44:33+00:00,report click,0.2802823483943939
2020-04-23 19:17:45+00:00,resubmits supplemental biologics license applications sblas keytruda registered pembrolizumab dosing schedule,-0.0174971483647823
2020-04-23 18:25:03+00:00,calculated expected return,-0.2707715034484863
2020-04-23 18:01:02+00:00,wondering risks volatility,-0.9974579811096193
2020-04-23 17:51:45+00:00,stocktwits trending recent interest,0.7507902383804321
2020-04-23 16:00:27+00:00,resubmits applications keytruda dosing schedule,0.0997167900204658
2020-04-23 15:47:42+00:00,uptrend moving average divergence macd turned positive view odds money news,0.960663914680481
2020-04-23 14:25:57+00:00,expect earnings,-0.0501436367630958
2020-04-23 12:49:25+00:00,resubmits supplemental biologics license applications fda regarding updating dosing frequency,-0.0373013541102409
2020-04-23 12:25:43+00:00,pre refiles application dosing keytruda sa,-0.9224933385849
2020-04-23 11:48:32+00:00,smart move dosing sbla,0.9736534357070924
2020-04-23 11:42:06+00:00,resubmits sblas keytruda dosing schedule,-0.0070713944733142
2020-04-23 11:33:10+00:00,resubmits supplemental biologics license applications sblas keytruda registered pembrolizumab dosing,-0.0300031192600727
2020-04-23 11:09:05+00:00,resubmits supplemental biologics license applications sblas keytruda registered pembrolizumab dosing schedule,-0.0293449535965919
2020-04-23 10:59:09+00:00,refiles application dosing keytruda,-0.0343934744596481
2020-04-23 10:55:39+00:00,resubmits supplemental biologics license applications sblas keytruda registered pembrolizumab dosing schedule,-0.0174971483647823
2020-04-23 10:52:13+00:00,resubmits sblas fda keytruda dosing schedule,-0.0495625287294387
2020-04-23 10:50:51+00:00,resubmits sblas keytruda dosing schedule,-0.0268089100718498
2020-04-23 10:48:21+00:00,unprecedented living cancer unwavering latest oncology update,0.4269862174987793
2020-04-23 10:47:18+00:00,resubmits supplemental biologics license applications keytruda registered dosing schedule,-0.0037484616041183
2020-04-23 09:32:17+00:00,security national bank grows position,0.3719930350780487
2020-04-23 08:12:17+00:00,cut raymond james financial services advisors,-0.5988727807998657
2020-04-23 08:07:17+00:00,nicolet advisory services boosts position,0.7409321069717407
2020-04-24 23:36:11+00:00,delta expiration,-0.0154787972569465
2020-04-24 22:33:33+00:00,registered olaparib demonstrated overall survival benefit phase profound brca metastatic prostate cancer,0.7296990156173706
2020-04-24 20:48:35+00:00,latest prostatecancer update,0.1580007076263427
2020-04-24 20:31:11+00:00,guess,0.0822618901729583
2020-04-24 18:27:31+00:00,sigma counselors position,0.1722451746463775
2020-04-24 17:19:07+00:00,close,-0.3287736475467682
2020-04-24 16:58:08+00:00,invhs esix,0.0699999034404754
2020-04-24 16:27:40+00:00,reports earnings opens wallstreet estimate mean estimate low estimate investingnews stockmarketnews,0.53397536277771
2020-04-24 15:31:32+00:00,reliable dividend dividend screen,0.9588160514831544
2020-04-24 15:23:03+00:00,world america lost soles lesson small world need gather happen,-0.6932399272918701
2020-04-24 15:21:08+00:00,invhs esix,0.0277887098491191
2020-04-24 15:05:06+00:00,low participating,-1.024946212768555
2020-04-24 14:55:14+00:00,raising write,0.9704416990280152
2020-04-24 14:46:21+00:00,,-0.0041209571063518
2020-04-24 14:44:32+00:00,earnings showing fuel big sector otherwise reporting companies area reporting along show,0.9752061367034912
2020-04-24 14:35:42+00:00,pps,0.1691576689481735
2020-04-24 14:13:47+00:00,home gamers dry powder end block help pps earnings,0.8575390577316284
2020-04-24 13:52:06+00:00,chain taken low little jelly,-1.0384933948516846
2020-04-24 13:43:40+00:00,stop train monorail tram,0.3527057468891144
2020-04-24 13:37:42+00:00,stc apr exp,0.0606334209442138
2020-04-24 12:34:40+00:00,grades show real soon eye eye eye ear collision,0.9663392305374146
2020-04-24 11:52:32+00:00,,0.9167262315750122
2020-04-24 11:41:32+00:00,positive studies news road lets save lives moat studies,0.9940589666366576
2020-04-24 11:27:02+00:00,registered olaparib demonstrated overall survival benefit phase profound brca,0.8386512994766235
2020-04-24 11:02:27+00:00,announces demonstrated os benefit phase profound brca metastatic prostate cancer,0.7356317043304443
2020-04-24 11:00:41+00:00,latest prostatecancer update,0.0980582609772682
2020-04-24 10:57:30+00:00,registered demonstrated overall survival benefit phase profound brca metastatic prostate cancer,0.7262245416641235
2020-04-24 10:12:40+00:00,resubmits supplementalbiologicslicenseapplications sblas keytruda registered pembrolizumab dosing schedule,-0.0248626768589019
2020-04-24 09:31:28+00:00,uptrend moving average divergence macd crosses signal line view odds money news,0.9489938020706176
2020-04-25 17:02:22+00:00,app,0.1562585085630417
2020-04-25 16:48:42+00:00,oi app,0.2098144441843032
2020-04-25 16:37:39+00:00,acquired montecito bank trust,0.4226504266262054
2020-04-25 16:26:03+00:00,,0.3010084927082062
2020-04-25 16:19:02+00:00,calculated expected return,-0.2450939714908599
2020-04-25 15:37:30+00:00,report earnings apr bmo expected move,0.545487642288208
2020-04-25 10:32:38+00:00,sicart,-0.7119756937026978
2020-04-25 09:30:25+00:00,moving average crossed moving average view odds money news,0.8968733549118042
2020-04-26 19:31:55+00:00,long term term dip late closes cover marketinsurance,-1.046441674232483
2020-04-26 16:52:49+00:00,position reduced financial management professionals,-0.9733633995056152
2020-04-26 12:27:47+00:00,sta wealth management acquires,0.294665664434433
2020-04-26 09:57:46+00:00,merriman wealth management purchases,0.1932279765605926
2020-04-26 09:06:31+00:00,moving average broke moving average view odds money news,0.8920172452926636
2020-04-26 07:47:46+00:00,gilman hill asset management boosts,0.8351396322250366
2020-04-26 07:40:05+00:00,currently rising horizontal resistance currently horizontal resistance ar,0.9048360586166382
2020-04-26 05:19:25+00:00,scheduled earnings,0.036451905965805
2020-04-26 05:17:49+00:00,scheduled earnings,0.036451905965805
2020-04-26 05:17:01+00:00,scheduled earnings,0.036451905965805
2020-04-26 04:41:37+00:00,currently rising horizontal resistance currently horizontal resistance around horizontal around able break failed keep eye forward,-1.0484601259231567
2020-04-27 22:59:53+00:00,institute biology announced collaboration investigate define molecular,0.0375271402299404
2020-04-27 22:15:00+00:00,institute biology announced collaboration investigate define molecular mechanisms infection covid identify targets medicines vaccines barda,0.0766695290803909
2020-04-27 21:30:19+00:00,earnings preview,0.0608889311552047
2020-04-27 21:24:00+00:00,former head ww vaccines blockbuster gardasil fox biz show explaining dual action host directed oral drug advantages chairman covid task force principal investigator trail soon,0.4636066257953644
2020-04-27 20:34:31+00:00,move significant changes,0.7838858366012573
2020-04-27 20:07:55+00:00,whittier trust nevada acquires,0.2622700035572052
2020-04-27 20:03:39+00:00,flow update optionsflow healthcare,0.896658182144165
2020-04-27 19:32:25+00:00,beats min,0.7625221014022827
2020-04-27 19:21:47+00:00,updates announce earnings,0.3389119505882263
2020-04-27 19:20:02+00:00,problem reporting show everyone company,0.9666775465011596
2020-04-27 19:08:06+00:00,important remember finasteride propecia proscar increased risk endocrine disorders covid complications covidsafe,-0.9203509092330932
2020-04-27 18:56:11+00:00,long earnings,0.9507330656051636
2020-04-27 18:00:38+00:00,reports open estimize consensus eps revs compared ws,0.1729004681110382
2020-04-27 18:00:15+00:00,hrs regular,0.3115500211715698
2020-04-27 17:23:19+00:00,active eps outlook,0.7641826868057251
2020-04-27 17:22:13+00:00,div pay date long term,0.9510411024093628
2020-04-27 16:58:25+00:00,fuck run numbers,-1.0056072473526
2020-04-27 16:36:29+00:00,boy girls glad earnings volatility optimistic forward glta curtain clear tower ride,0.9784973859786988
2020-04-27 15:58:04+00:00,reports open usually early around,0.2044517546892166
2020-04-27 15:38:16+00:00,smart saving lot lives large moat diverse chain products bayer discontinue chronic cough study already approved,0.9384335279464722
2020-04-27 15:23:30+00:00,around mda,0.8439091444015503
2020-04-27 14:59:12+00:00,simple reasoning pps escalate pasts darken glta,0.9577809572219848
2020-04-27 14:52:08+00:00,reversal green,0.9612358808517456
2020-04-27 14:37:16+00:00,cake walk gut soon,0.279458999633789
2020-04-27 14:06:38+00:00,let dogs,-0.7122455835342407
2020-04-27 13:59:09+00:00,shine,0.9658420085906982
2020-04-27 12:54:13+00:00,early birds worm,0.2276539653539657
2020-04-27 12:47:20+00:00,interesting health care general long respect glta,0.9725950956344604
2020-04-27 12:24:52+00:00,pre isb investigate mechanisms covid infection sa,-0.8853574991226196
2020-04-27 12:16:07+00:00,news clearly vaccines party,0.9639204740524292
2020-04-27 11:51:34+00:00,isb investigate mechanisms covid infection,-0.1133859008550643
2020-04-27 11:49:32+00:00,announced presentation interim data cohort keynote phase evaluating,0.8552675247192383
2020-04-27 11:34:10+00:00,moving average crossed moving average view odds money news,0.8968733549118042
2020-04-27 11:33:25+00:00,latest oncology update,0.2208184748888015
2020-04-27 11:08:46+00:00,isb investigate mechanisms covid infection,-0.1026457250118255
2020-04-27 11:03:44+00:00,isb investigate mechanisms covid infection,-0.1041088104248046
2020-04-27 11:02:44+00:00,announced presentation interim data cohort keynote phase evaluating mg every dosing regimen keytruda therapy patients metastatic melanoma,0.5990880727767944
2020-04-27 10:59:30+00:00,latest oncology update,0.2052239626646042
2020-04-27 10:58:41+00:00,institute biology collaborate define molecular mechanisms infection identify potential prognostic biomarkers,0.0532725043594837
2020-04-27 10:52:09+00:00,research collaboration consortium research biomed companies identify potential biomarkers,0.2494548708200454
2020-04-27 10:46:41+00:00,institute biology collaborate define molecular mechanisms infection identify potential prognostic biomarkers,0.0673811286687851
2020-04-27 09:10:26+00:00,sciencemag york clinical quietly tests heartburn remedy coronavirus famotidine clinical antacid michael callahan massachusetts general hospital stunning article,0.2656170427799225
2020-04-27 08:12:52+00:00,shufro rose boosts stake,0.4978441298007965
2020-04-27 06:27:25+00:00,demonstrated overall survival benefit phase iii profound metastaticcastrationresistant prostatecancer,0.8810161352157593
2020-04-27 05:47:48+00:00,set announce earnings,0.0413286499679088
2020-04-27 05:17:52+00:00,set announce earnings,0.0516066774725914
2020-04-27 05:15:46+00:00,set announce earnings,0.0413286499679088
2020-04-27 05:14:11+00:00,set announce earnings,0.0413286499679088
2020-04-27 05:13:26+00:00,set announce earnings,0.0413286499679088
2020-04-27 00:42:50+00:00,bought mufg americas corp,0.5059736967086792
2020-04-28 23:50:47+00:00,latest oncology update,0.3296181559562683
2020-04-28 22:39:44+00:00,receives fda approval additional recommended dosage mg every keytruda,0.0613141767680645
2020-04-28 22:25:04+00:00,earnings intelligence analysis recent earnings identified nyse focus keytruda tumor dna keytruda tumors keytruda mutations tumors,0.121847853064537
2020-04-28 21:44:27+00:00,let ball rolling fastest approvals recent memory fda oks dosing keytruda,0.7721105813980103
2020-04-28 21:27:22+00:00,prior dosing every alternate regimen doubles dosage halves number visits expect change driver lower overall charges administering therapy full course treatment,0.0794648230075836
2020-04-28 21:14:30+00:00,fda approves dosing keytruda monotherapy alternative regimen instead,-0.0124441236257553
2020-04-28 21:13:37+00:00,fda approves dosing keytruda monotherapy alternative regimen instead fda action insofar regimen reduces patient needs visit clinic pandemic,0.2140590697526931
2020-04-28 21:06:13+00:00,issues earnings results,0.0758006945252418
2020-04-28 21:05:23+00:00,issues earnings results,0.1269176453351974
2020-04-28 21:01:42+00:00,fda oks dosing keytruda,0.0484611392021179
2020-04-28 20:57:00+00:00,keytruda dosing approved fda announcement resubmission approval took,0.7505679130554199
2020-04-28 20:56:45+00:00,fda oks dosing keytruda,0.0484611392021179
2020-04-28 20:52:50+00:00,announced fda approved additional recommended dosage every keytruda across adult including monotherapy combination therapy,0.1202444359660148
2020-04-28 20:43:57+00:00,latest oncology update,0.2765686511993408
2020-04-28 20:36:00+00:00,lowered revenue expectations vaccines cancer drugs animal health face pressures,-0.8564873933792114
2020-04-28 20:14:28+00:00,ceo ken frazier explains company fight coronavirus pandemic,0.007692128419876
2020-04-28 19:59:59+00:00,eps beats gaap eps beats revenue beats,0.7852960824966431
2020-04-28 19:48:33+00:00,ceo ken frazier results earnings transcript bu,0.0293842144310474
2020-04-28 19:48:06+00:00,ceo ken frazier results earnings transcript,0.0831563621759414
2020-04-28 19:15:13+00:00,big powerfull sector stay course,0.9307581186294556
2020-04-28 18:58:46+00:00,despite beating estimates,-0.7854126691818237
2020-04-28 18:48:51+00:00,issues earnings results beats estimates eps,0.2575991749763489
2020-04-28 18:48:29+00:00,baml us objective change guidance cuts doghouse thoughts neutral,-0.8479396104812622
2020-04-28 18:47:53+00:00,announces earnings results beats estimates eps,0.4368948638439178
2020-04-28 18:42:55+00:00,jimcramer berniemadoff ceo speaking bet snake oil remdisivir,-0.4413254261016845
2020-04-28 18:38:59+00:00,nj governor phil murphy adding ceo ken frazier commission restarting economy push reopen country coronavirus,0.0526979565620422
2020-04-28 18:29:53+00:00,ceo ken frazier explains company fight coronavirus pandemic,0.0283785462379455
2020-04-28 18:03:06+00:00,ceo cnbc discuss earnings let reverse,0.1575226783752441
2020-04-28 17:58:15+00:00,updates fy earnings guidance,0.0523354671895504
2020-04-28 17:32:56+00:00,low needs upwards movement fill gap less resistance way given fills almost immediately tight,0.7846126556396484
2020-04-28 17:32:07+00:00,earnings results live full financial summary key highlights,0.2510314881801605
2020-04-28 17:30:04+00:00,bythenumbers highlights earnings report,0.0169075429439544
2020-04-28 16:50:23+00:00,earnings preliminary transcript pharmaceuticals earnings,0.0170922428369522
2020-04-28 16:30:08+00:00,tumbles dow component forecasts impact coronavirus pandemic fiscal quarters earnings,-0.8040125370025635
2020-04-28 16:30:08+00:00,tumbles dow component forecasts impact coronavirus pandemic fiscal quarters earnings,-0.8040125370025635
2020-04-28 16:19:09+00:00,sales warning,-0.0504637993872165
2020-04-28 16:13:10+00:00,starts feel covid effects,-0.0926283150911331
2020-04-28 16:03:19+00:00,update investorplace mission control pharmaceutical struggling drug sales drop,-1.0693968534469604
2020-04-28 15:58:37+00:00,reaping dividends helps,0.9715205430984496
2020-04-28 15:48:20+00:00,later earnings,0.7747069597244263
2020-04-28 15:41:46+00:00,zacks ready upgrade revenue report,0.984628438949585
2020-04-28 15:25:11+00:00,pharma sales overall sales billion profit billion life priceless,0.8733711242675781
2020-04-28 14:58:26+00:00,updates fy earnings guidance,0.0523354671895504
2020-04-28 14:53:51+00:00,updates fy earnings guidance,0.0714775025844574
2020-04-28 14:51:17+00:00,earnings move expected move,-0.0363813936710357
2020-04-28 14:42:46+00:00,michael levesque anticipated sales rebound addition underlying products lead sales rebound pandemic eventually ebbs,0.9831746816635132
2020-04-28 14:41:50+00:00,beleave upgrades,0.9630234241485596
2020-04-28 14:35:56+00:00,moody senior vice president michael levesque weighs earnings impact coronavirus pharma,-0.1073479205369949
2020-04-28 14:19:58+00:00,guard golden eggs,0.9875096082687378
2020-04-28 14:02:54+00:00,real bad,-0.3858712613582611
2020-04-28 14:02:12+00:00,quick scalp,-0.9103049039840698
2020-04-28 13:55:53+00:00,weak hung vwap ww flat bottom need pull help,-1.0602470636367798
2020-04-28 13:46:07+00:00,eps beats estimate sales beat estimate earnings,0.8840433359146118
2020-04-28 13:44:11+00:00,results earnings presentation economy,0.084984466433525
2020-04-28 13:34:41+00:00,solid company revenue saving life helping animals health bless,0.996994972229004
2020-04-28 13:29:17+00:00,covid impact,0.0407418385148048
2020-04-28 13:29:12+00:00,baml surprised modest pressure given negative implications,-1.080538630485535
2020-04-28 13:29:02+00:00,management prudent upstanding possible head winds prudent imo,0.9634273052215576
2020-04-28 13:10:43+00:00,earnings revenues estimates,0.8624844551086426
2020-04-28 13:10:03+00:00,heads approaching,0.9136359691619872
2020-04-28 13:09:09+00:00,premarket billion hit sales coronavirus pandemic earnings,-0.9205117225646972
2020-04-28 13:07:10+00:00,eps beats beats revenue,0.4970614016056061
2020-04-28 13:04:30+00:00,earnings david risinger morgan stanley analyst jokingly asked official comment disinfectant uv light potential coronavirus medicines,0.120367407798767
2020-04-28 12:50:33+00:00,beats beats revs lowers eps guidance consensus revs consensus,-0.8346282243728638
2020-04-28 12:30:57+00:00,pre profit beats coronavirus uncertainty weighs,-0.2145239561796188
2020-04-28 12:28:27+00:00,lowering rev eps guidance considering impacts keytruda money lung cancer speculate impact longer cancer diagnosis delayed survival rate declines due virus,-0.8881803750991821
2020-04-28 12:12:13+00:00,adj eps beats estimate sales beat estimate eps,0.5240551233291626
2020-04-28 12:06:16+00:00,baml surprised modest pressure given negative implications revision raise question whether amendments outlook pandemic continues unfold,-1.0787194967269895
2020-04-28 12:04:02+00:00,clinical outcomes evaluating dosing schedule keytruda registered pembrolizumab presented,0.0876782983541488
2020-04-28 12:03:22+00:00,adj eps beats estimate sales beat estimate eps est sales est,0.4748320281505584
2020-04-28 12:02:40+00:00,bythenumbers highlights earnings report,0.0554186813533306
2020-04-28 12:01:36+00:00,eps beats beats revenue nyse eps beats gaap eps beats revenue beats,0.8521498441696167
2020-04-28 11:54:32+00:00,advanced discussions multiple focusing different viral vaccine platforms details future,0.0841996893286705
2020-04-28 11:51:25+00:00,keytruda sales guidance lowered due covid impact,0.0392622873187065
2020-04-28 11:50:57+00:00,earnings revenue exp adj eps exp lowers revenue range,-0.0895173847675323
2020-04-28 11:35:12+00:00,profit rises cuts forecast covid uncertainty,0.571195125579834
2020-04-28 11:34:06+00:00,earnings warns lower sales,0.2277748584747314
2020-04-28 11:31:50+00:00,reports beats numbers lowers guidance premarket,0.9508844614028932
2020-04-28 11:30:19+00:00,us et learn earnings,0.2151167243719101
2020-04-28 11:29:04+00:00,us et learn earnings,0.2491958886384964
2020-04-28 11:27:59+00:00,covid impact,0.0214415341615676
2020-04-28 11:22:37+00:00,ra patients younger disease mostly chronic unfortunately lung melanoma etc patients succumb disease eventually hand always drug inflation,-0.9366044998168944
2020-04-28 11:18:40+00:00,date announced little way drug development seems changing,-0.2012317776679992
2020-04-28 11:17:07+00:00,cuts guidance covid pandemic toll keytruda vaccines,-0.7415148019790649
2020-04-28 11:14:07+00:00,eps beats consensus,0.3998441994190216
2020-04-28 11:12:52+00:00,advanced discussions multiple focusing different viral vaccine platforms details collaborations announced necessary arrangements finalize,0.0407448858022689
2020-04-28 11:12:02+00:00,calculated expected return,0.8288919925689697
2020-04-28 11:11:10+00:00,regarding virus started broad drug development program builds experience vaccines antiviral medications,0.001760434359312
2020-04-28 11:08:18+00:00,lowers fy eps view,-0.9645156860351562
2020-04-28 11:08:07+00:00,lowering revenue estimate impact coronavirus,-0.9948302507400512
2020-04-28 11:07:01+00:00,sec filing form,0.0169025622308254
2020-04-28 11:05:47+00:00,reports sales increase period keytruda sales,0.9559894800186156
2020-04-28 10:58:01+00:00,lowers fy eps view,-0.961174249649048
2020-04-28 10:56:45+00:00,eps beats beats revenue,0.5400816202163696
2020-04-28 10:55:55+00:00,adj eps beats est sales beat est eps es,0.5002585649490356
2020-04-28 10:55:51+00:00,company sec filing form,-0.0701673179864883
2020-04-28 10:51:25+00:00,eps revenues beat lowers eps revenue guidance consensus,0.2054691910743713
2020-04-28 10:51:08+00:00,adj eps beats est sales beat est eps est sales est,0.4322774112224579
2020-04-28 10:50:44+00:00,accurate estimate analyst beating analysts wall street consensus,0.7897094488143921
2020-04-28 10:50:42+00:00,beats estimize eps consensus estimize revenue consensus reports earnings eps revs,0.7466635704040527
2020-04-28 10:50:39+00:00,reports earnings eps revs,0.1688257455825805
2020-04-28 10:48:39+00:00,due impact covid company lowers gaap eps range lowers,-0.0793291181325912
2020-04-28 10:48:18+00:00,due impact covid company lowers gaap eps range lowers eps range including negative impact foreign exchange approximately,-1.0476744174957275
2020-04-28 10:47:47+00:00,shocked,-1.0374349355697632
2020-04-28 10:47:17+00:00,earnings revenue exp adj eps exp lowers revenue range,-0.3430846631526947
2020-04-28 10:47:06+00:00,keytruda billion,0.1440730541944503
2020-04-28 10:46:48+00:00,earnings results live full financial summary key highlights,0.2128342986106872
2020-04-28 10:46:03+00:00,scheduled announce earnings results open consensus eps estimate consensus revenue estimate earnings,0.6247225999832153
2020-04-28 09:32:53+00:00,uptrend moving average divergence macd crosses signal line view odds money news,0.9489938020706176
2020-04-28 05:27:01+00:00,wallstreet,0.1186129599809646
2020-04-28 04:23:02+00:00,book value,0.6823546886444092
2020-04-28 04:18:01+00:00,unicorn bay rating,0.3191361427307129
2020-04-28 02:59:21+00:00,app,0.1562585085630417
2020-04-29 22:42:29+00:00,usmarkets mega healthcare technical analysis,0.951967716217041
2020-04-29 19:55:21+00:00,land dime,0.9450087547302246
2020-04-29 19:43:26+00:00,received letter president trump signed frame,0.9435479640960692
2020-04-29 19:41:11+00:00,earnings results beats expectations eps,0.3329212367534637
2020-04-29 19:40:53+00:00,issues fy earnings guidance,0.0417633987963199
2020-04-29 19:38:41+00:00,target lowered barclays,-0.9682822227478028
2020-04-29 19:26:30+00:00,bots almost eye ear real,0.7026196718215942
2020-04-29 19:19:00+00:00,hump afterall kick,0.9533261060714722
2020-04-29 19:15:22+00:00,folks lets special,0.9908801317214966
2020-04-29 19:09:34+00:00,robinhoodapp stillwatchlist startsmall,0.1000927612185478
2020-04-29 16:37:24+00:00,manual exit closing position opened gain,0.9370406866073608
2020-04-29 15:33:33+00:00,pt lowered,-0.9473607540130616
2020-04-29 15:28:47+00:00,almost eu close play min,0.5509557723999023
2020-04-29 15:25:00+00:00,analysts focus fundamentals keytruda strength guidance cut,-0.7559970617294312
2020-04-29 14:55:16+00:00,gains profit sales beat outlook downbeat however oxford university world effective vaccine,0.9347823858261108
2020-04-29 14:55:11+00:00,long close,0.0709080621600151
2020-04-29 14:11:05+00:00,hook zip line,0.2991538941860199
2020-04-29 13:58:40+00:00,gild,0.1173671633005142
2020-04-29 13:53:41+00:00,gild headline stooled little fire us play settles,0.1109183579683303
2020-04-29 12:04:01+00:00,upgrades place seat belt,0.7913651466369629
2020-04-29 11:36:46+00:00,pt raised barclays,0.900000810623169
2020-04-29 11:35:13+00:00,upward targets add kitty,0.9709912538528442
2020-04-29 11:30:45+00:00,,0.9696918725967408
2020-04-29 11:19:49+00:00,fda approves keytruda registered pembrolizumab additional recommended dose mg every approved adult,0.901503324508667
2020-04-29 10:25:25+00:00,turn green red,-0.0308307893574237
2020-04-29 09:25:19+00:00,uptrend moving average divergence macd crosses signal line view odds money news,0.9489938020706176
2020-04-29 03:36:30+00:00,receives fda approval additional recommended dosage mg every keytruda htt,0.1145076900720596
2020-04-29 02:27:35+00:00,beat bottom lines sales bln gaap income bln,0.8639264106750488
2020-04-29 02:18:04+00:00,max pain maturity,-0.111636146903038
2020-04-29 01:47:00+00:00,beat bottom lines sales bln gaap income bln lowered guidance due covid flagship drug keytruda sales bln dividend,0.90216064453125
2020-04-29 01:24:51+00:00,pause yrs civid hurts given heavy doctor admin products fx,-1.083142638206482
2020-04-29 00:52:02+00:00,recommendation ub rating,-0.2410321235656738
2020-04-29 00:29:27+00:00,dividend rating candidate dividend,0.9550071954727172
2020-05-03 22:54:14+00:00,mean crypto afterall money volatility ploys simple washing excercises thing gullible holders lose everytime kurtosis skewness distribution returns latest auctions plutocracy,0.9669421911239624
2020-05-03 18:59:34+00:00,acquired chartwell partners,0.4082000851631164
2020-05-03 18:15:49+00:00,janney capital management raises position,0.6960735321044922
2020-05-03 17:39:35+00:00,narwhal capital management grows,0.714261531829834
2020-05-03 17:12:33+00:00,banque pictet cie sa million,0.147798091173172
2020-05-03 17:01:45+00:00,illinois municipal retirement fund million stake,0.203742429614067
2020-05-03 16:40:03+00:00,targitting,-0.0156897865235805
2020-05-03 15:56:32+00:00,personal cfo solutions million,0.1008530482649803
2020-05-03 15:15:30+00:00,bessemer securities boosts,0.6741716861724854
2020-05-03 13:52:31+00:00,dakota wealth management reduces position,-0.6967477798461914
2020-05-03 10:12:02+00:00,btw estimated earnings current,0.4583513140678406
2020-05-03 09:34:18+00:00,downtrend moving average divergence macd turned negative view odds othe,-1.0884195566177368
2020-05-03 09:30:03+00:00,unicorn bay rating,0.3308245837688446
2020-05-03 08:24:28+00:00,downtrend moving average divergence macd turned negative view odds money news,-1.0829312801361084
2020-05-03 08:16:34+00:00,directional bias report click details,-0.7779198884963989
2020-05-03 08:12:41+00:00,report click,0.2802823483943939
2020-05-03 05:47:01+00:00,earnings estimate issued svb leerink,0.0384973473846912
2020-05-03 05:45:57+00:00,earnings estimate issued svb leerink,0.0384973473846912
2020-05-03 05:43:30+00:00,earnings estimate issued svb leerink,0.0522832982242107
2020-05-04 21:05:49+00:00,delta expiration,-0.018617033958435
2020-05-04 16:27:41+00:00,rating reiterated credit ag pt,0.8651648759841919
2020-05-04 14:54:45+00:00,gs signals large biopharma acquirers picking sanofi highlighting gene therapy interest,0.7829583883285522
2020-05-04 14:25:48+00:00,dddd pharma intro microbiome unicorn,0.9645845890045166
2020-05-04 12:50:16+00:00,reiterated bycredit,0.90359365940094
2020-05-04 12:44:49+00:00,rating reiterated credit,0.2689386308193207
2020-05-04 12:43:40+00:00,rating reiterated credit,0.2689386308193207
2020-05-04 11:49:30+00:00,rating reiterated credit,0.4059645235538482
2020-05-04 09:35:03+00:00,downtrend moving average divergence macd turned negative view odds money news,-1.0829312801361084
2020-05-04 08:34:11+00:00,dddd pharma intro microbiome unicorn signed vaccine licence deal keytruda phase ii cancer alongside lbt potential covid treatment clinical,0.9798202514648438
2020-05-04 07:45:46+00:00,eps estimates reduced cantor fitzgerald,-0.9876612424850464
2020-05-05 23:50:18+00:00,insider filing evp chief commercial officer frank clyburn,0.0467276871204376
2020-05-05 22:54:17+00:00,insider filing evp general counsel jennifer zachary,0.0501331500709056
2020-05-05 22:50:17+00:00,insider filing sr vp controller rita karachun,0.0430259928107261
2020-05-05 22:46:19+00:00,insider filing chairman president ceo kenneth frazier,0.0565238893032074
2020-05-05 22:46:01+00:00,small action jul drug plays,-0.2122230231761932
2020-05-05 21:37:16+00:00,insider filing exe pres mmd sanat chattopadhyay,0.0461426600813865
2020-05-05 21:03:52+00:00,app,0.1562585085630417
2020-05-05 20:55:04+00:00,company sec filing form,-0.0484154559671878
2020-05-05 19:43:47+00:00,power close,0.035417653620243
2020-05-05 19:14:49+00:00,filling gap upward,0.0806554481387138
2020-05-05 17:39:20+00:00,commits additional million covid relief efforts help disparately impacted patients communities,0.8060410022735596
2020-05-05 16:20:38+00:00,apears sector beach,0.2315754741430282
2020-05-05 14:30:27+00:00,alarmingly vaccine appeared increase rate hiv infection individuals prior immunity adenovirus vector vaccine ade antibody dependent enhancement hiv vaccines treatment implications,0.8625985383987427
2020-05-05 14:24:11+00:00,headed,0.5152170658111572
2020-05-05 12:45:03+00:00,surprising data point disclosed keytruda sales covered entities evidence program unexpectedly large pharma discounts,0.197715938091278
2020-05-05 11:04:45+00:00,commits additional million covid relief efforts help disparately impacted patients,0.8054190874099731
2020-05-05 10:55:32+00:00,commits additional million covid relief efforts help disparately impacted patients communities,0.8580276966094971
2020-05-05 08:53:25+00:00,earnings estimate issued cantor fitzgerald,0.0666541010141372
2020-05-05 08:52:03+00:00,earnings estimate issued cantor fitzgerald,0.0666541010141372
2020-05-05 07:53:15+00:00,brokers issue forecasts earnings,-0.2447824329137802
2020-05-05 06:08:51+00:00,turn green red,-0.0178564935922622
2020-05-06 23:32:17+00:00,insider filing sr vp controller rita karachun,0.0430259928107261
2020-05-06 23:14:26+00:00,showing dividend selection,0.9697375297546388
2020-05-06 23:11:19+00:00,insider filing svp chief ethics officer michael fleming,0.0499591752886772
2020-05-06 21:16:40+00:00,company sec filing form,-0.0484154559671878
2020-05-06 18:44:50+00:00,learn latest news infectiousdiseases,0.3801568150520324
2020-05-06 17:32:16+00:00,hump turn corner,0.3183093667030334
2020-05-06 14:06:58+00:00,machine enjoy gift,0.9822213649749756
2020-05-06 14:02:59+00:00,results phase evaluating efficacy safety recarbrio imipenem cilastatin relebactam versus piperacillin tazobactam adult patients habp vabp available,0.2797662317752838
2020-05-06 13:34:30+00:00,easy,0.96509051322937
2020-05-06 12:50:20+00:00,announces results phase clinical evaluating recarbrio treatment,-0.0413974523544311
2020-05-06 12:28:17+00:00,insider filing evp chief officer michael nally,0.0559068545699119
2020-05-06 12:09:17+00:00,insider filing exe pres mrl roger perlmutter,0.0459611564874649
2020-05-06 11:17:03+00:00,announces results phase evaluating recarbrio versus piperacillin tazobactam adult patients habp vabp available,0.2115799486637115
2020-05-06 11:07:57+00:00,major quote changes,0.1548679620027542
2020-05-06 11:00:01+00:00,results phase evaluating efficacy safety recarbrio imipenem cilastatin,0.2349910289049148
2020-05-06 10:55:02+00:00,results phase evaluating efficacy safety recarbrio imipenem cilastatin relebactam versus piperacillin tazobactam adult patients habp vabp available,0.2914058864116668
2020-05-06 10:49:33+00:00,learn latest news infectiousdiseases,0.3638583421707153
2020-05-06 09:55:50+00:00,aroon drops downtrend view odds money news,-1.076823592185974
2020-05-06 09:42:48+00:00,earnings svb leerink forecasts,0.3363118171691894
2020-05-06 09:07:24+00:00,earnings svb leerink forecasts,0.3363118171691894
2020-05-06 08:37:17+00:00,earnings svb leerink forecasts,0.3363118171691894
2020-05-06 08:36:25+00:00,research analysts set expectations earnings,0.0855654627084732
2020-05-06 08:33:28+00:00,research analysts set expectations earnings,0.0855654627084732
2020-05-06 08:33:20+00:00,research analysts set expectations earnings,0.0855654627084732
2020-05-06 07:04:17+00:00,insider filing evp strat comm gi pub policy gerberding,0.0452404730021953
2020-05-06 06:51:16+00:00,insider filing svp chief ethics officer michael fleming,0.0499591752886772
2020-05-06 04:58:18+00:00,insider filing evp pres animal heallth richard deluca,0.0445935651659965
2020-05-06 03:10:17+00:00,insider filing evp chief hr officer steven mizell,0.048746895045042
2020-05-06 01:24:06+00:00,domain therapeutics receives development milestone payment kgaa darmstadt germany adenosine receptor antagonist strategic assets pipeline,0.1947578340768814
2020-05-06 01:01:18+00:00,insider filing evp global svcs cfo robert davis,0.0447906330227851
2020-05-07 23:59:19+00:00,insider filing director leslie brun,0.0547561459243297
2020-05-07 23:45:01+00:00,director wendell,-0.7674075365066528
2020-05-07 22:38:32+00:00,wendell,-0.7210276126861572
2020-05-07 22:36:31+00:00,director wendell,-0.4419125914573669
2020-05-07 21:40:22+00:00,leslie brun dumps,-0.9418410062789916
2020-05-07 20:54:50+00:00,company sec filing form,-0.0484154559671878
2020-05-07 20:54:01+00:00,insider,-1.0529016256332395
2020-05-07 19:15:06+00:00,reported eps sales bil eps sales eps grew,0.9618664979934692
2020-05-07 18:43:12+00:00,present bofa securities health care conference,0.0048141553997993
2020-05-07 16:02:05+00:00,present data broad oncology portfolio pipeline asco virtual scientific program,0.1620094627141952
2020-05-07 15:59:01+00:00,showing lift pps,0.5747636556625366
2020-05-07 15:14:28+00:00,fear factor causing bot mode,-1.060494065284729
2020-05-07 15:06:45+00:00,set eggs hand cards showing near term,0.969574213027954
2020-05-07 14:49:45+00:00,struggling lately feel missing,-1.0615965127944946
2020-05-07 14:38:08+00:00,present bofa securities health care conference,0.0048141553997993
2020-05-07 13:17:59+00:00,plenary session feature phase data keytruda registered pembrolizumab dmmr colorectal cancer data keytruda tumor types including breast cancer classical hodgkin lymphoma cell lung cancer rcc,0.0779140889644622
2020-05-07 13:15:51+00:00,present data broad oncology portfolio pipeline asco virtual scientific program,0.1620094627141952
2020-05-07 12:47:13+00:00,downtrend moving average divergence macd turned negative view odds money news,-1.0829312801361084
2020-05-07 10:59:27+00:00,reveal findings oncology program cancer oncology,0.1190833449363708
2020-05-07 10:59:17+00:00,proud present bofa securities health care conference,0.93279767036438
2020-05-07 10:46:46+00:00,latest oncology data studies conversation,0.3395535051822662
2020-05-07 05:22:07+00:00,starting weaken recrosses bearish lower bb rolling opening tr,-1.0854798555374146
2020-05-07 04:46:18+00:00,insider filing evp general counsel jennifer zachary,0.0501331500709056
2020-05-07 04:34:16+00:00,insider filing evp chief officer michael nally,0.0559068545699119
2020-05-07 03:26:38+00:00,breaks moving average sentiment neutral,-1.0040843486785889
2020-05-07 00:06:19+00:00,insider filing evp chief commercial officer frank clyburn,0.0467276871204376
2020-05-08 23:45:51+00:00,astrazeneca announce fda approved epithelial ovarian fallopian tube,0.1855059713125229
2020-05-08 23:29:50+00:00,registered olaparib approved fda maintenance treatment bevacizumab advanced,0.855420708656311
2020-05-08 23:29:24+00:00,registered olaparib approved fda maintenance treatment bevacizumab advanced ovarian cancer,0.7319437265396118
2020-05-08 21:36:33+00:00,registered olaparib approved fda maintenance treatment bevacizumab,0.8412274122238159
2020-05-08 21:29:16+00:00,learn recent update ovariancancer,0.1510354578495025
2020-05-08 21:26:01+00:00,registered approved fda maintenance treatment bevacizumab advanced ovarian cancer,0.6928979158401489
2020-05-08 18:00:23+00:00,company pick stockchase finance stockpicks,0.9871031045913696
2020-05-08 18:00:18+00:00,company us company finance stockpicks,0.9131320714950562
2020-05-08 15:53:10+00:00,cfra adds portfolio rating tp,0.960007905960083
2020-05-08 13:27:20+00:00,credit reaffirms rating,0.9086083173751832
2020-05-08 12:19:22+00:00,director wendell,-0.4419125914573669
2020-05-08 12:19:15+00:00,director wendell,-0.4419125914573669
2020-05-08 12:17:23+00:00,announces virtual meeting,0.0249849148094654
2020-05-08 10:58:44+00:00,announces virtual meeting,0.0249849148094654
2020-05-08 10:56:06+00:00,meeting held virtually learn,0.008015651255846
2020-05-08 10:48:23+00:00,meeting held virtually learn,0.0357306078076362
2020-05-08 10:40:02+00:00,downtrend moving average divergence macd turned negative view odds money news,-1.0829312801361084
2020-05-08 05:53:08+00:00,present bofa securities health care conference,0.0048141553997993
2020-05-08 03:01:17+00:00,insider filing director wendell,0.0497046485543251
2020-05-09 19:07:34+00:00,earnings expected quarter,0.518466591835022
2020-05-09 15:32:00+00:00,missing boat,-1.045998215675354
2020-05-09 12:29:40+00:00,upcoming event bofa securities health care conference expiring cover event implied move,0.2355734854936599
2020-05-09 09:36:12+00:00,aroon drops downtrend view odds money news,-1.0772112607955933
2020-05-09 09:23:45+00:00,wendell,-0.7210276126861572
2020-05-09 09:21:14+00:00,director,-0.8114035129547119
2020-05-09 09:13:18+00:00,technical narrow range bar cup handle,-0.0668615028262138
2020-05-09 09:03:33+00:00,kgaa kgaa agm general agm held form virtual agm accordance german law mitigate consequences covid pandemic physical presence authorised,-0.0844051167368888
2020-05-09 08:14:32+00:00,learn recent update ovariancancer,0.1772086322307586
2020-05-09 05:33:06+00:00,futhan nafamostat mesilate drug treating acute pancreatitis studied japan avigan favipar,-0.026069987565279
2020-05-28 23:06:03+00:00,announces keytruda monotherapy significantly reduced risk disease progression death,-0.0306372940540313
2020-05-28 22:49:55+00:00,adverse events conclusions keynote dr thierry andré,-0.1743035465478897
2020-05-28 22:49:50+00:00,keytruda registered pembrolizumab plus lenvima registered lenvatinib combination demonstrated clinically meaningful tumor,0.4673613011837005
2020-05-28 22:41:26+00:00,collaboration exploring patients living kidneycancer livercancer learn data,0.6029987335205078
2020-05-28 22:38:44+00:00,keytruda registered plus lenvima registered combination demonstrated clinically meaningful tumor response rates unresectable hepatocellular carcino,0.5138977766036987
2020-05-28 22:24:46+00:00,keytruda registered superior standard care chemotherapy patients colorectal cancer,0.8128596544265747
2020-05-28 21:41:51+00:00,optimus maximus est opened corp chance avg avg loss avg id stats,0.8733588457107544
2020-05-28 21:36:55+00:00,keytruda line treatment doubles pfs colorectal cancer patients certain dna mutation,0.5843216180801392
2020-05-28 21:19:32+00:00,keytruda registered pembrolizumab superior standard care chemotherapy patients colorectal cancer,0.9228299856185912
2020-05-28 21:16:10+00:00,keytruda registered pembrolizumab superior standard care chemotherapy patients colorectal,0.9164299964904784
2020-05-28 21:06:47+00:00,pfs kn curves cross psuedoprogression hardly events around median long tail cure,0.3530265092849731
2020-05-28 21:04:34+00:00,adverse events conclusions keynote dr thierry andré,-0.1110510155558586
2020-05-28 21:02:17+00:00,keytruda pembrolizumab superior standard care chemotherapy patients colorectal cancer related tickers,0.9134255647659302
2020-05-28 21:01:51+00:00,unwavering commitment cancer community bring patients latest oncology update,0.7021031379699707
2020-05-28 20:37:20+00:00,hat ring virus,0.2773396968841553
2020-05-28 20:31:23+00:00,rising declining appearances performance close later avg worst later avg worst later avg worst,-0.8760040998458862
2020-05-28 19:38:15+00:00,themis bioscience innovative young biotech company promising platform technology acquired us big pharma comp,0.976455807685852
2020-05-28 19:11:42+00:00,earnings summary,0.0244509167969226
2020-05-28 15:48:17+00:00,stop entry lod,-1.0070875883102417
2020-05-28 15:29:01+00:00,,-0.0587130784988403
2020-05-28 15:12:56+00:00,bought,0.9381684064865112
2020-05-28 15:07:54+00:00,radar story,-0.0283560007810592
2020-05-28 14:33:02+00:00,spree drug giant partnering local startup develop patch,0.0428735986351966
2020-05-28 14:13:39+00:00,add watchlist late,-0.0160137191414833
2020-05-28 14:07:54+00:00,bouncing,0.970456600189209
2020-05-28 13:47:37+00:00,added,0.8559621572494507
2020-05-28 13:37:43+00:00,optimus maximus est opened corp chance avg avg loss avg id stats,0.8763312101364136
2020-05-28 13:36:16+00:00,surprised muted response mkt news playing catch,-0.9089800119400024
2020-05-28 12:19:29+00:00,line positive,0.9333423376083374
2020-05-28 09:57:43+00:00,preferential access themis potential covid vaccine ceo coronavirus,0.020803727209568
2020-05-28 09:26:19+00:00,moving average moved moving average view odds money news,0.910811185836792
2020-05-28 07:00:21+00:00,merckco bidaskscore lowered,-0.9709243774414062
2020-05-28 04:29:10+00:00,sentiment total scores positive negative sentiment,-0.050377283245325
2020-05-28 01:54:33+00:00,eisen misrepresent favorite recent moment attacked ceo vaccine development line conservative classy response,0.9312077760696412
2020-05-29 23:22:01+00:00,kenneth frazier race clear steady objectives shot big,0.2883286774158478
2020-05-29 22:20:50+00:00,hear thoughts either though,0.0024266988039016
2020-05-29 21:35:54+00:00,kenneth frazier race clear steady objectives shot big multiple studies proven tech platform someone adult room,0.6910780668258667
2020-05-29 20:13:50+00:00,guys,-0.0048232786357402
2020-05-29 19:28:20+00:00,ya bought,0.957332730293274
2020-05-29 16:19:14+00:00,files form submission matters vote security holders form,0.0407510362565517
2020-05-29 15:45:05+00:00,asco keytruda standard cancer oncology,0.078214131295681
2020-05-29 14:55:12+00:00,weak technical analysis score ta score categories score excellent moving average score poor score weak,-0.990619659423828
2020-05-29 14:29:28+00:00,keytruda registered pembrolizumab plus lenvima registered lenvatinib combination demonstrated clinically meaningful tumor response rates unresectable hepatocellularcarcinoma advanced renalcellcarcinoma,0.8517041206359863
2020-05-29 14:26:02+00:00,keytruda registered pembrolizumab superior standard care chemotherapy patients msih colorectalcancer,0.9103809595108032
2020-05-29 13:56:04+00:00,announced keytruda plus lenvima combination demonstrated clinically meaningful tumor response rates unresectable hepatocellular carcinoma advanced renal cell carcinoma related tickers,0.814635157585144
2020-05-29 13:33:00+00:00,flight,0.0872434675693512
2020-05-29 12:01:06+00:00,pre keytruda lenvima shows benefit liver kidney cancers sa,0.8921911716461182
2020-05-29 11:52:36+00:00,pre keytruda lenvima shows benefit liver kidney cancers sa,0.8507498502731323
2020-05-29 11:48:10+00:00,moving average broke moving average view odds money news,0.8921972513198853
2020-05-29 11:28:26+00:00,keytruda lenvima shows benefit liver kidney cancers,0.7588087320327759
2020-05-29 11:27:47+00:00,keytruda lenvima shows benefit liver kidney cancers,0.7588087320327759
2020-05-29 07:04:54+00:00,flow update optionsflow healthcare,0.8550266027450562
2020-05-29 05:51:46+00:00,update preferential access themis potential covid vaccine ceo coronavirus,0.0368397161364555
2020-05-29 03:56:02+00:00,mizhou keynote pfs significance asco late breaker relevance reduced risk disease,0.8314826488494873
2020-05-29 03:49:00+00:00,long vaccine patch delivery tech pandemic potential,0.950193166732788
2020-05-29 01:30:05+00:00,announces keytruda monotherapy significantly reduced risk disease progression death,-0.3566142618656158
2020-05-29 01:27:18+00:00,mizhou keynote pfs significance asco late breaker relevance reduced risk disease progression death versus standard care soc hr keytruda soc responses durable,0.8842352628707886
2020-05-30 22:30:11+00:00,major changes,0.306290328502655
2020-05-30 20:49:06+00:00,receives consensus recommendation analysts,0.8555986881256104
2020-05-30 20:46:16+00:00,receives consensus recommendation analysts,0.8555986881256104
2020-05-30 15:07:56+00:00,interest,0.5241380929946899
2020-05-30 14:41:32+00:00,ahead biotech asco menlo fda decisions ipos spotlight,0.0025481395423412
2020-05-30 11:56:28+00:00,clear risk,-1.0082653760910034
2020-05-30 10:00:38+00:00,moving average crossed moving average view odds money news,0.8971023559570312
2020-05-30 06:40:54+00:00,george floyd family deserve justice families killed vioxx drugs justiceforgeorgefloyd minneapolisuprising minneapolisprotests riots ahmaudarbery arrestkenfrazier arrestraygilmartin,-0.3318096697330475
2020-05-30 04:29:54+00:00,form submission matters vote security meeting held voted matters set fort,0.0850650742650032
2020-05-30 02:16:55+00:00,jun,0.8864892721176147
2020-05-30 02:00:00+00:00,markhillman hedgefund continues,0.18728868663311
2020-05-31 21:06:55+00:00,max pain maturity,-0.1083481311798095
2020-05-31 20:59:39+00:00,news keytruda excellent data patients mutation burden oncology,0.9824929237365724
2020-05-31 20:46:45+00:00,keytruda phase study shows double progression untreated colon cancer dmmr mutations hinder dna repair standard chemotherapy regiment keytruda statnews asco seconds newsletter,0.9382305145263672
2020-05-31 16:43:40+00:00,stake lessened ars partners,-0.5495576858520508
2020-05-31 15:50:04+00:00,directional bias report click details,-0.7779198884963989
2020-05-31 15:48:37+00:00,report click,0.2802823483943939
2020-05-31 13:21:46+00:00,max pain maturity,-0.0233973562717437
2020-05-31 13:02:19+00:00,unveils virus vaccine candidates warning timeline,-0.0493859983980655
2020-05-31 12:12:02+00:00,worth position bottoms change recently,0.9540355205535888
2020-05-31 11:51:53+00:00,dr bright raised concern barda demoted nih drbright,0.5126692056655884
2020-05-31 11:44:57+00:00,dr bright raised concern barda demoted nih drbright,-0.1405027210712433
2020-05-31 08:54:52+00:00,moving average moved moving average view odds money news,0.910811185836792
2020-05-31 02:32:03+00:00,,0.1742499470710754
2020-05-31 00:50:45+00:00,max pain maturity,-0.1083481311798095
2020-05-31 00:25:29+00:00,catch,0.3224327862262726
2020-06-01 23:02:51+00:00,need black daughter killing george floyd,-0.7712883949279785
2020-06-01 22:58:52+00:00,quote ken frazier rings loud,-0.0367160886526107
2020-06-01 22:23:20+00:00,profitable company growing industry boxes dividend yield growth rate low,0.9680473804473876
2020-06-01 20:30:59+00:00,avg appearances performance close later avg worst later avg worst later avg worst,-0.899850606918335
2020-06-01 20:02:49+00:00,optimus maximus est closed covered previously loss corp id stats,-1.077039122581482
2020-06-01 19:26:10+00:00,finally ready,0.672209620475769
2020-06-01 19:17:41+00:00,profitable company growing industry boxes dividend yield growth rate low beta long term appears enough money handle debts,0.9729900360107422
2020-06-01 19:09:26+00:00,,-0.0866816565394401
2020-06-01 18:57:57+00:00,yes,0.8468433618545532
2020-06-01 18:48:07+00:00,ceo speaks racial injustice blacklivesmatter businessleaders corporateamerica georgefloyd murder policebrutality protests racism,-0.1402791142463684
2020-06-01 17:16:09+00:00,outstanding leader saw live powerful,0.9371159076690674
2020-06-01 17:02:29+00:00,rock,0.9881720542907716
2020-06-01 16:48:51+00:00,ceo cnbc,0.076121911406517
2020-06-01 16:25:55+00:00,change recently,0.0353864468634128
2020-06-01 15:32:31+00:00,growing moat larger glta,0.8977420330047607
2020-06-01 15:19:24+00:00,,-1.0120805501937866
2020-06-01 15:16:08+00:00,interview gerberding chief patient officer hope,-0.0240432955324649
2020-06-01 14:56:54+00:00,quote ken frazier rings loud,-0.0705324485898017
2020-06-01 14:50:36+00:00,millions medicalvape story,-0.0069610550999641
2020-06-01 14:28:02+00:00,important interview ceo ken frazier georgefloyd racism american well worth minutes life,0.4098437130451202
2020-06-01 14:13:34+00:00,ken frazier,0.8908809423446655
2020-06-01 14:08:26+00:00,ceo,0.0783307179808616
2020-06-01 14:05:37+00:00,ceo person speak situation substance convo matters lot,0.2933953106403351
2020-06-01 13:51:39+00:00,ceo kenneth frazier george floyd,0.0447485148906707
2020-06-01 13:49:03+00:00,ken frazier continues serve gold standard leadership leadership probably serve us well arenas,0.9556347131729126
2020-06-01 13:42:23+00:00,long,0.9168388843536376
2020-06-01 13:22:37+00:00,recent pancreaticcancer update,-0.0360758975148201
2020-06-01 13:13:01+00:00,behind everyday cnbc nobody gives shit mentoring dollahs robots mr ken proud represent mr ken,0.9973978996276855
2020-06-01 12:59:07+00:00,sounded ceo endorsed busing,0.2645855844020843
2020-06-01 12:47:49+00:00,astrazeneca azn confirm received positive opinion eu chmp maintenance,0.9284363985061646
2020-06-01 12:43:57+00:00,kennethfrazier africanamerican ceo pharma company valuation billion joebiden needs give spot administration,0.0377960801124572
2020-06-01 12:43:09+00:00,kennethfrazier africanamerican ceo pharma company valuation billion joebiden needs give spot administration,-0.2121472805738449
2020-06-01 12:26:02+00:00,ceo,0.0402204692363739
2020-06-01 12:23:42+00:00,impressive informative inspirational full practical suggestions kudos blessed leader,0.942297339439392
2020-06-01 12:23:11+00:00,slide overman discussant kn study,-0.2900506258010864
2020-06-01 12:22:12+00:00,interestingly michael overman discussant assume os benefit kn,0.8138480186462402
2020-06-01 12:21:13+00:00,michael overman discussant kn study comments pfs curves crossing,-0.0559757985174655
2020-06-01 12:19:17+00:00,ken frazier ceo yes kenfrazier makeamericamoreequitable,0.6447993516921997
2020-06-01 12:15:01+00:00,registered olaparib receives positive opinion eu chmp maintenance treatment patients germline metastatic pancreatic cancer,0.923200249671936
2020-06-01 12:11:20+00:00,ceo,0.0238915309309959
2020-06-01 11:18:37+00:00,registered olaparib receives positive opinion eu chmp maintenance treatment patients,0.9254820346832277
2020-06-01 10:57:51+00:00,registered receives positive opinion eu chmp maintenance treatment patients germline,0.9267597198486328
2020-06-01 10:47:35+00:00,recent pancreaticcancer update,-0.0346789211034774
2020-06-01 10:06:29+00:00,bill cosby thought crimes buried past figured never receive justice wrong fate awaits murderers criminals liars cowards justiceforgeorgefloyd usaonfire minneapolisriot minneapolisuprising,-0.6452780961990356
2020-06-01 09:24:37+00:00,entry change recently,0.899438738822937
2020-06-01 09:12:54+00:00,moving average moved moving average view odds money news,0.910811185836792
2020-06-01 08:41:17+00:00,brokerages expect eps,0.0747684761881828
2020-06-01 04:49:18+00:00,company nyse impulse wave visit detailed frame analysis,-0.066454216837883
2020-06-01 03:43:57+00:00,broad turning green big green reversal change recently,0.617568850517273
2020-06-01 02:06:44+00:00,designate terrorist organization justiceforahmaudarbery justiceforvioxxvictims justiceforgeorgesfloyd arrestkenfrazier,-0.8360581398010254
2020-06-02 23:56:30+00:00,insider filing director leslie brun,0.0547561459243297
2020-06-02 22:59:29+00:00,insider filing director patricia russo,0.0490371510386467
2020-06-02 22:58:31+00:00,insider filing director inge thulin,0.049750231206417
2020-06-02 22:53:54+00:00,director bought show helps cause speaks,0.9688155651092528
2020-06-02 22:38:22+00:00,full ken frazier cnbc interview whole thing,0.3161298930644989
2020-06-02 22:02:22+00:00,insider filing director peter wendell,0.0535744428634643
2020-06-02 21:45:40+00:00,acquired thulin inge director reported form filed sec,0.2079410851001739
2020-06-02 21:15:40+00:00,acquired craig pamela director reported form filed sec,0.1742845028638839
2020-06-02 20:57:44+00:00,baml concerned dominant positioning keytruda monotherapy emphasized,0.7166279554367065
2020-06-02 20:31:11+00:00,engulfing appearances performance close later avg worst later avg worst later avg worst,-0.6842824220657349
2020-06-02 20:24:51+00:00,column multi sector bet sarscov waited bring covid fight,0.9856430292129515
2020-06-02 20:15:09+00:00,ceo ken frazier dominates,-0.0632553920149803
2020-06-02 19:58:48+00:00,baml concerned dominant positioning keytruda monotherapy emphasized room activity novel agents combowith pd antibodies lot wood chop tigit meaningful competitor,0.9230625629425048
2020-06-02 18:38:00+00:00,became major player global push develop medicines covid daria hazuda vice president infectious disease discovery spoke biopharma dive company plans,0.4557946622371673
2020-06-02 17:54:11+00:00,bmy breakout getter real bad,-1.027090549468994
2020-06-02 17:36:05+00:00,bmy horse race surprise,0.941887617111206
2020-06-02 15:10:00+00:00,powerful statements biggest names pharma,0.9726119041442872
2020-06-02 14:02:54+00:00,full ken frazier cnbc interview whole thing,0.3348907828330993
2020-06-02 13:59:30+00:00,bought,0.918687105178833
2020-06-02 13:38:25+00:00,pharma leadership long term pipeline drugs approved development current valuation compared definitely attractive,0.9820141792297364
2020-06-02 11:07:41+00:00,full interview ceo ken frazier cnbc everyone beyond statements step address world continuing results racial prejudice country,-0.003077570348978
2020-06-02 09:56:28+00:00,moved moving average view odds money news,0.9073276519775392
2020-06-02 02:30:38+00:00,need black daughter killing george floyd,-0.7712883949279785
2020-06-02 02:25:38+00:00,blackhill capital,-0.8679413795471191
2020-06-02 00:52:43+00:00,ken frazier philly,0.0261855088174343
2020-06-02 00:41:51+00:00,ceo george floyd,0.060929786413908
2020-06-02 00:39:20+00:00,simply,-1.0522643327713013
2020-06-02 00:38:10+00:00,profound genuine statement cxo regarding recent acts black mortality long ceo kenneth frazier george floyd,-0.0447898432612419
2020-06-02 00:07:19+00:00,movement,0.5261485576629639
2020-06-02 00:05:38+00:00,thomas white international,0.1381452083587646
2020-06-03 23:38:00+00:00,powerhouse preparing leap past roche leave gilead bristol myers behind race tigit domination,-0.0959719344973564
2020-06-03 23:34:26+00:00,congratulations,0.4177019894123077
2020-06-03 22:18:09+00:00,presents asco slideshow finance,-0.0002796277403831
2020-06-03 20:36:35+00:00,rising appearances performance close later avg worst later avg worst later avg worst,-0.0249098464846611
2020-06-03 19:58:27+00:00,big,0.9252253770828248
2020-06-03 19:40:29+00:00,jp continue adjuvant potential upside driver longer term keytruda estimates provided updates,0.9803080558776855
2020-06-03 19:36:39+00:00,already brands index pharma bios,-0.4278790056705475
2020-06-03 19:06:21+00:00,studies safety efficacy humans begin,0.6413919925689697
2020-06-03 18:55:12+00:00,yes bad third covid program antiviral ridgeback vaccine,-0.9634171724319458
2020-06-03 18:42:39+00:00,jp continue adjuvant potential upside driver longer term keytruda estimates provided updates clinical program adjuvant neoadjuvant studies running represent upside keytruda longer term slidedeck,0.9843202829360962
2020-06-03 18:41:45+00:00,pick every single,0.2044140994548797
2020-06-03 18:27:17+00:00,,0.9298831224441528
2020-06-03 17:42:42+00:00,article vaccine programs selected,0.0129048340022563
2020-06-03 16:27:07+00:00,rest pharma sector moves help village raise sector progresses,0.9903885126113892
2020-06-03 16:17:10+00:00,list clearly track pps dd direction vix helping encourage finally,0.9704525470733644
2020-06-03 15:09:24+00:00,movement,0.9617429971694946
2020-06-03 14:52:14+00:00,happy director bought jamie diamond bought outright changes glta,0.9593772888183594
2020-06-03 14:25:24+00:00,lot flash pan treatments fading fast dd well platforms prudent moves long way,0.9609931707382202
2020-06-03 13:59:00+00:00,,0.9570066928863524
2020-06-03 13:54:06+00:00,gain possibly enough otherwise sit hands chill,0.9105724096298218
2020-06-03 13:32:44+00:00,optimus maximus est closed covered previously loss corp id stats,-1.0748273134231567
2020-06-03 12:53:41+00:00,inside,0.0298413187265396
2020-06-03 11:40:35+00:00,insider filing director pamela craig,0.0473060384392738
2020-06-03 11:13:17+00:00,moved moving average view odds money news,0.9073276519775392
2020-06-03 09:12:13+00:00,expected sales billion,0.0780007094144821
2020-06-03 09:12:00+00:00,expected sales billion,0.0780007094144821
2020-06-03 07:08:29+00:00,insider filing director thomas cech,0.0474987514317035
2020-06-03 07:00:31+00:00,waited bring covid fight,-0.06973247975111
2020-06-03 06:55:41+00:00,acquired wendell peter director reported form filed sec,0.1824139058589935
2020-06-03 06:50:41+00:00,acquired warden kathy director reported form filed sec,0.1850991994142532
2020-06-03 05:08:56+00:00,form initial statement beneficial ownership securities filed sec,0.7626422643661499
2020-06-03 05:05:56+00:00,acquired risa director reported form filed sec,0.2346840351819992
2020-06-03 05:03:56+00:00,acquired seidman christine director reported form filed sec,0.185028076171875
2020-06-03 04:51:56+00:00,acquired brun leslie director reported form filed sec,0.2118686586618423
2020-06-03 04:47:55+00:00,acquired cech thomas director reported form filed sec,0.1561015844345092
2020-06-03 04:43:55+00:00,acquired coe mary ellen director reported form filed sec,0.1930857300758361
2020-06-03 04:39:55+00:00,acquired glocer thomas director reported form filed sec,0.1783276498317718
2020-06-03 04:37:55+00:00,acquired rothman paul director reported form filed sec,0.1789126992225647
2020-06-03 04:33:57+00:00,acquired russo patricia director reported form filed sec,0.161012202501297
2020-06-03 04:29:56+00:00,acquired craig pamela director reported form filed sec,0.1742845028638839
2020-06-03 04:22:55+00:00,acquired wendell peter director reported form filed sec,0.1824139058589935
2020-06-03 04:21:55+00:00,acquired warden kathy director reported form filed sec,0.1850991994142532
2020-06-03 04:10:29+00:00,insider filing director kathy warden,0.0511661581695079
2020-06-03 03:47:58+00:00,acquired thulin inge director reported form filed sec,0.2079410851001739
2020-06-03 03:45:55+00:00,king wealth million,0.1927912831306457
2020-06-03 03:30:40+00:00,king wealth million,0.1927912831306457
2020-06-03 03:19:29+00:00,insider filing director mary ellen coe,0.0507217086851596
2020-06-03 01:24:32+00:00,insider filing director thomas glocer,0.0464786365628242
2020-06-03 01:01:52+00:00,management presents oncology event asco conference transcript ec,-0.0457907058298587
2020-06-03 01:00:00+00:00,elfun trusts keeps,0.1306118965148925
2020-06-03 00:50:09+00:00,management presents oncology event asco conference transcript economy,-0.020249493420124
2020-06-03 00:19:20+00:00,awesome company,0.9667454957962036
2020-06-04 23:21:59+00:00,earnings expected quarter,0.4238735735416412
2020-06-04 22:50:26+00:00,fda approves recarbrio treatment bacterial pneumonia,-0.0032057985663414
2020-06-04 22:45:31+00:00,fda approves recarbrio treatment bacterial pneumonia,0.0429233238101005
2020-06-04 21:12:08+00:00,moat wider deeper reason gov part virus patrol agreed hard vaccine,0.9733588695526124
2020-06-04 21:06:12+00:00,winner,0.9670529365539552
2020-06-04 20:56:46+00:00,fda oks antibiotic bacterial pneumonia,0.0320371054112911
2020-06-04 20:41:07+00:00,fda oks antibiotic bacterial pneumonia,0.0320371054112911
2020-06-04 19:42:35+00:00,cs purchased,-1.0014921426773071
2020-06-04 19:29:00+00:00,crook insider keep,-1.0378276109695437
2020-06-04 19:22:55+00:00,insider,-1.0102906227111816
2020-06-04 19:17:00+00:00,icymi major player global push develop medicines covid daria hazuda vice president infectious disease discovery spoke plans,0.4124458134174347
2020-06-04 19:00:05+00:00,,0.1518163233995437
2020-06-04 16:32:45+00:00,insider keep,-1.019473433494568
2020-06-04 16:19:39+00:00,ex dividend,0.3815264999866485
2020-06-04 16:04:04+00:00,booming raid,-0.7163790464401245
2020-06-04 15:15:00+00:00,point lift long value imo,0.9721336364746094
2020-06-04 15:11:17+00:00,excellent technical analysis score ta score categories score excellent moving average score excellent score excellent,0.961639165878296
2020-06-04 10:22:26+00:00,moved moving average view odds money news,0.9073276519775392
2020-06-04 10:13:56+00:00,ask,-0.0100626088678836
2020-06-05 20:21:01+00:00,fda approves recarbio treatment adults bacterial pneumonia,0.0610473863780498
2020-06-05 19:49:18+00:00,insider,-0.9817215204238892
2020-06-05 19:18:41+00:00,delta expiration,-0.0174848027527332
2020-06-05 18:59:44+00:00,end run,0.643589973449707
2020-06-05 17:16:06+00:00,expiration open interest open interest,0.9199199676513672
2020-06-05 15:22:34+00:00,navellier,-0.6949812173843384
2020-06-05 15:00:11+00:00,merckco bidaskscore increased held,0.9245249032974244
2020-06-05 14:45:14+00:00,push sma sma slightly sloppy ihs nonetheless squeeze firing long planning common move sma needs clearance,-1.0468721389770508
2020-06-05 14:37:23+00:00,proud latest news infectiousdiseases,0.9492326974868774
2020-06-05 13:56:08+00:00,long,0.5988837480545044
2020-06-05 13:31:10+00:00,big dogs,0.9784914255142212
2020-06-05 13:17:25+00:00,bmy hole village move,0.545180082321167
2020-06-05 12:52:39+00:00,recarbrio imipenem cilastatin relebactam received fda approval treatment adults,0.0661539584398269
2020-06-05 12:33:36+00:00,,-0.0055695585906505
2020-06-05 12:19:05+00:00,fda approves recarbrio imipenem cilastatin relebactam treatment adults hospital,0.0304335728287696
2020-06-05 11:51:34+00:00,fda approves recarbrio imipenem cilastatin relebactam treatment adults bacterial pneumonia habp vabp,0.0873606652021408
2020-06-05 11:49:08+00:00,fda approves recarbrio imipenem cilastatin relebactam treatment adults bacterial pneumonia habp vabp,0.0600309520959854
2020-06-05 11:01:14+00:00,fda approves recarbrio imipenem cilastatin relebactam treatment adults,0.1459042429924011
2020-06-05 10:59:51+00:00,fda approves recarbio treatment adults bacterial pneumonia,0.0770873874425888
2020-06-05 10:55:43+00:00,delayed issued press release fda approves recarbrio imipenem cilastatin relebactam treatment adults bacterial pneumonia habp vabp,-0.5837371349334717
2020-06-05 10:53:00+00:00,proud latest news infectiousdiseases,0.9549766778945924
2020-06-05 10:52:14+00:00,fda approves recarbrio imipenem cilastatin relebactam treatment adults bacterial pneumonia habp vabp,0.0873606652021408
2020-06-05 09:42:04+00:00,moved moving average view odds money news,0.9073276519775392
2020-06-06 22:38:01+00:00,third fda nod antibiotic mereo tackles tigit raise hand,0.8056448698043823
2020-06-06 21:40:22+00:00,slower peers edges covid fight,-1.0302793979644775
2020-06-06 21:07:23+00:00,alphacrest capital management grows,0.6432946920394897
2020-06-06 09:32:57+00:00,uptrend moving average divergence macd crosses signal line view odds money news,0.9489938020706176
2020-06-06 00:57:39+00:00,power open interest update optionsflow,0.5358395576477051
2020-06-07 22:08:02+00:00,saturna capital corp acquires,0.2512500286102295
2020-06-07 20:13:11+00:00,delta management,0.2151997685432434
2020-06-07 20:07:53+00:00,acquired westpac banking corp,0.3776184916496277
2020-06-07 17:57:29+00:00,wintrust,-0.886432409286499
2020-06-07 09:09:51+00:00,uptrend moving average divergence macd crosses signal line view odds money news,0.9489938020706176
2020-06-07 05:47:04+00:00,collaboration discover develop proprietary influenza antiviral agents program provide,-0.0761068984866142
2020-06-08 22:09:20+00:00,blockbuster stat conversations interview gerberding,-0.0798584595322609
2020-06-08 19:28:20+00:00,jeff interconnected interest ensuring health around world prevent types spreads decimate populations biodigital,0.9370216131210328
2020-06-08 19:24:03+00:00,dont ta atm fomo excitment coinbasepro real catalyst coinbase cb cheers mate,0.840701699256897
2020-06-08 19:21:18+00:00,note lot manufacturing figures percentages jeff cited drugs apis versus overseas conflicts fda reported biodigital,-0.2708495855331421
2020-06-08 19:17:06+00:00,jeff insists came pandemic strength happen overnight result policies encouraged biotech gold standard world nih academic institutions incentivized act biodigital,0.9632953405380248
2020-06-08 19:14:36+00:00,international covid brian pomper jeff keith rockwell exports pomper mind introduced speakers panel exports biodigital,0.0304485633969306
2020-06-08 18:32:16+00:00,movement entered avg bid always step ahead crowd,0.7238715887069702
2020-06-08 18:27:28+00:00,bought,0.8680386543273926
2020-06-08 18:11:58+00:00,ready,0.4678103029727936
2020-06-08 18:01:49+00:00,blockbuster stat conversations interview gerberding company efforts interview cms director seema verma,-0.064762182533741
2020-06-08 17:58:02+00:00,global wealth management advisory raises position,0.7267651557922363
2020-06-08 17:50:52+00:00,keeping eyes stays,0.2457464188337326
2020-06-08 16:27:30+00:00,pps headed soon,0.0262070223689079
2020-06-08 16:00:00+00:00,expiration open interest open interest,0.8925349712371826
2020-06-08 15:45:03+00:00,notes young scientist created fellowship program thanks leading opportunities scientists talent wasted unless fostered progress achieved biodigital,0.597527265548706
2020-06-08 15:41:54+00:00,generation scientist prepared politics science weight began mount biotech wrapped arms around notes industry fellowship rescued biodigital,0.8472957611083984
2020-06-08 12:46:28+00:00,simply outstanding well thought company,0.965961217880249
2020-06-08 09:41:55+00:00,uptrend moving average divergence macd turned positive view odds money news,0.960663914680481
2020-06-08 04:43:48+00:00,black father processes killing george floyd black father,-0.6887054443359375
2020-06-09 23:55:00+00:00,recent bladdercancer update,-0.0123626105487346
2020-06-09 23:03:01+00:00,update bladder cancer study fails meet main goals,-1.0668680667877195
2020-06-09 22:16:32+00:00,provides update phase keynote keytruda monotherapy combination,-0.0229270756244659
2020-06-09 22:10:34+00:00,provides update phase keynote keytruda monotherapy combination,0.0147632323205471
2020-06-09 21:36:50+00:00,keytruda flunks bladder cancer study,-0.0603653937578201
2020-06-09 21:26:43+00:00,phase keynote evaluating keytruda meet dual primary endpoints,-0.5562952756881714
2020-06-09 21:11:49+00:00,keynote evaluating keytruda combination chemotherapy treatment patients ad,0.115538015961647
2020-06-09 21:08:56+00:00,keytruda flunks bladder cancer study,-0.0603653937578201
2020-06-09 21:00:05+00:00,give sentiment score scale moderate activity social media recently,-0.9804586172103882
2020-06-09 20:34:46+00:00,john markels running full capacity pandemic search cupboards biodigital vaccines,-0.0808039084076881
2020-06-09 20:31:20+00:00,dark cloud cover appearances performance close later avg worst later avg worst later avg worst,-1.0074998140335083
2020-06-09 20:30:35+00:00,gerberding thing worry vaccine nationalism everybody concerne,-0.4578191041946411
2020-06-09 20:17:44+00:00,provides update phase keynote evaluating keytruda registered pembrolizumab monotherapy,0.1532113254070282
2020-06-09 20:17:21+00:00,john markels technical human resources vaccinologists limited resource trouble biodigital vaccines,-0.93253493309021
2020-06-09 20:16:07+00:00,john markels vaccine characteristics scaleable usable idea platform powerful biodigital vaccines,1.002690076828003
2020-06-09 20:14:23+00:00,markels things typically done enough capacity manufacture scale needs mechanism identify leading candidates help decisions move capacity impact biodigital,0.9210430383682252
2020-06-09 20:12:16+00:00,john markels kitchen sink everybody find scale quickly throwing kitchen sink billion vaccine already intensive biodigital vaccines,0.0421261712908744
2020-06-09 20:11:23+00:00,john markels less vaccine industry running capacity lot additional excess capacity around long build context embarking ambitious efforts biodigital vaccines,0.4225063025951385
2020-06-09 20:09:41+00:00,oops well words wisdom stonks,0.2732812464237213
2020-06-09 20:09:13+00:00,recent bladdercancer update,-0.0353539884090423
2020-06-09 20:07:23+00:00,phase keynote evaluating keytruda meet dual primary endpoints,-0.7986994981765747
2020-06-09 20:06:28+00:00,keynote evaluating keytruda combination chemotherapy treatment patients advanced metastatic urothelial carcinoma bladder cancer meet dual primary endpts os pfs soc,0.1637472212314605
2020-06-09 19:50:00+00:00,john markels feel special responsibility side humans side mindless virus race us virus developing safe effective vaccine daunting challenge scale ebola biodigital,0.3474015891551971
2020-06-09 17:54:47+00:00,expiration open interest open interest,0.9177098274230956
2020-06-09 17:51:47+00:00,killed already friends along coinbase,0.9982141256332396
2020-06-09 17:44:36+00:00,gerberding chose platforms experience safety true rare events,0.8382912874221802
2020-06-09 17:27:42+00:00,vaccine optimist case gerberding reason vaccines animal coronaviru,-0.0707671046257019
2020-06-09 17:24:46+00:00,gerberding enough information neutralizing antibodies alone enough approval,0.1384340226650238
2020-06-09 17:10:09+00:00,gerberding former cdc director cdc treasure chest experts hopes,0.6401293277740479
2020-06-09 17:00:52+00:00,gerberding collaboration willingness help inspiring commitment company keeps product rich vaccines,1.0208832025527954
2020-06-09 17:00:10+00:00,ensuring equitable distribution vaccines gerberding nih coalition construct wish global apparatus thing help vulnerable countries low middle income countries hardest engage,0.6884496212005615
2020-06-09 16:56:51+00:00,hard test vaccines vaccines candidates gerberding transmission faster,-0.7420104742050171
2020-06-09 16:56:39+00:00,gerberding vaccines important engagement women childbearing age conversation often culturally dependent,0.3250795900821686
2020-06-09 16:55:21+00:00,gerberding fast shortchange safety assessment compressing timeline safety important skipping safety assessments vaccines,0.9209284782409668
2020-06-09 16:54:36+00:00,gerberding chose platforms experience safety true rare events seen vaccines given track record racing vaccines public health emergency,0.9288203716278076
2020-06-09 16:51:41+00:00,gerberding thing worry vaccine nationalism everybody concerned protecting country safe everyone safe vaccines,0.5817309617996216
2020-06-09 16:50:44+00:00,higher dose vaccine needed gerberding reason chose vaccines chose illicit broad response need vaccine notes populations need type protected,0.2484798580408096
2020-06-09 16:48:23+00:00,gerberding feel comfortable challenge treatment knew zero risk age affected virus immune serious outcome death vaccines,0.9088351726531982
2020-06-09 16:46:46+00:00,hard test vaccines vaccines candidates gerberding transmission faster answer efficacy unfortunately plenty hot spots surprised global situation pretty grim,-0.9737523794174194
2020-06-09 16:44:34+00:00,single dose vaccines gerberding answer question vaccines,0.0053456239402294
2020-06-09 16:41:44+00:00,realistic timelines gerberding decision approaches faster scale hope,0.3420658111572265
2020-06-09 16:41:42+00:00,realistic timelines gerberding decision approaches faster scale hope gate successful ultimately protect science stern task master things always turn,0.8629438877105713
2020-06-09 16:40:52+00:00,gerberding surprised vaccine without neutralizing antibody learn studies vaccines,0.2913084030151367
2020-06-09 16:40:39+00:00,gerberding alignment around global threat humans human economy overcomes lot territorial competitive ways usually things stay safe vaccines,0.800841212272644
2020-06-09 16:38:26+00:00,gerberding enough information neutralizing antibodies alone enough approval live chat,-0.0057003796100616
2020-06-09 16:38:17+00:00,gerberding partnerships came ebola exist ahead kind messy coordinate world environments never participating everyone page heroic lots came together,0.8245813846588135
2020-06-09 16:37:56+00:00,vaccine optimist case gerberding reason vaccines animal coronaviruses seen proof concept,-0.3572551310062408
2020-06-09 16:35:16+00:00,gerberding hiv emerged process figured drug vaccinate learned tremendous amount retroviruses knowledge informed drug helped us understand approach viruses vaccines,0.4804725646972656
2020-06-09 16:33:29+00:00,always pathogens imagined apparatus allows us proceed quickly past gerberding invent vaccines fast,-0.3266176879405975
2020-06-09 16:33:04+00:00,gerberding always pathogens imagined platform approach pursue fast vaccines,-0.1218217089772224
2020-06-09 16:32:10+00:00,timeline gerberding everyone understands parallel series vaccine never fast safety studies easy test environment cases measles construct iavi vax later,-0.4559111297130584
2020-06-09 16:28:05+00:00,gerberding important thing safety closely related vaccines behave differently safety vaccines,0.7038638591766357
2020-06-09 16:27:52+00:00,gerberding former cdc director cdc treasure chest experts hopes done,0.6141782999038696
2020-06-09 16:27:19+00:00,gerberding doubt vaccine race hopefully help everyone protected vaccines,0.7624894380569458
2020-06-09 16:26:59+00:00,gerberding doubt vaccine race everyone talking end benefit vaccine listen,0.9357261657714844
2020-06-09 16:26:31+00:00,gerberding quest find candidates took vaccine effective dose distributed anyone world tall order candidate based measles vax iavi backbone ebola vax true,0.9012625217437744
2020-06-09 16:23:28+00:00,gerberding scientists cdc treasure chest capability cdc trusted vaccines,0.8045504093170166
2020-06-09 16:23:09+00:00,gerberding impossible sars little déjà vu dodge bullet us devastating mortality impact economy harbinger taken heart position,0.8083093166351318
2020-06-09 15:12:11+00:00,stat conversations tap et speaks gerberding,-0.0711447894573211
2020-06-09 14:02:56+00:00,strugling near fail,-1.0726689100265503
2020-06-09 14:02:18+00:00,optimus maximus est opened corp chance avg avg loss avg id stats,0.8749871253967285
2020-06-09 12:48:41+00:00,stat conversations tap et speaks gerberding company et interviews cms director seema verma,-0.0422684550285339
2020-06-09 12:18:29+00:00,max pain maturity,-0.0214879959821701
2020-06-09 09:25:38+00:00,uptrend moving average divergence macd turned positive view odds money news,0.960663914680481
2020-06-09 07:02:46+00:00,showed score,0.9627331495285034
2020-06-09 06:38:47+00:00,bought banque cantonale vaudoise,0.6771937608718872
2020-06-09 06:33:45+00:00,stake lowered grantham mayo van otterloo,-0.8853225708007812
2020-06-09 04:25:08+00:00,downgraded valuengine,-1.0064295530319214
2020-06-09 04:06:44+00:00,downgraded valuengine,-1.0064295530319214
2020-06-10 23:06:31+00:00,thesis entry particular point solid well curious moment,0.8026173114776611
2020-06-10 21:22:18+00:00,risk reversal jul bot finance jul,-0.493950217962265
2020-06-10 21:00:50+00:00,asset management decreases stake,-0.8969180583953857
2020-06-10 20:19:32+00:00,mean stashstockparty giveaway taken,-1.0075125694274902
2020-06-10 20:03:24+00:00,mean stashstockparty giveaway taken timer elapses,-1.0218929052352903
2020-06-10 18:31:53+00:00,bsgm dip opp swing conf spring former lead worldwide live viral vaccine franchise talks vacci,-0.9728320837020874
2020-06-10 18:15:45+00:00,decided jump reason mentions,0.907631516456604
2020-06-10 16:57:05+00:00,fda approval phase bcgvaccine let hope helps fight,0.7582602500915527
2020-06-10 16:42:00+00:00,keytruda fails pivotal bladder cancer study sinks hopes,-0.9717748165130616
2020-06-10 14:55:17+00:00,,-0.0587130784988403
2020-06-10 14:14:14+00:00,drop always contracts less risky imo,-1.0775948762893677
2020-06-10 14:01:35+00:00,fail break,-1.0519912242889404
2020-06-10 11:42:12+00:00,provides update keytruda chemotherapy treatment advanced metastatic urothelialcarcinoma meet dual primary endpoints overall survival survival,0.755253791809082
2020-06-10 10:17:22+00:00,lyvgen announces clinical collaboration msd,0.0667859315872192
2020-06-10 09:50:20+00:00,moved moving average view odds money news,0.9073276519775392
2020-06-10 09:01:14+00:00,keytruda fails meet endpoints bladder cancer,-1.042377233505249
2020-06-10 07:56:03+00:00,full analysis kn interesting early analysis shown decreased os lows keytruda driven fail result suggests benefit either,-0.4805803000926971
2020-06-10 07:00:22+00:00,merckco bidaskscore lowered,-0.9709243774414062
2020-06-10 07:00:00+00:00,king keytruda flounders pivotal cancer study spur doubts staying power,-0.9898271560668944
2020-06-10 05:54:04+00:00,downgraded valuengine,-0.9645098447799684
2020-06-10 05:52:32+00:00,rating lowered valuengine,-0.8615813255310059
2020-06-10 05:50:23+00:00,rating lowered valuengine,-0.8615813255310059
2020-06-10 03:06:39+00:00,implied volatility expiration,-1.0686988830566406
2020-06-10 02:21:05+00:00,directional bias report click details,-0.7779198884963989
2020-06-10 02:17:58+00:00,report click,0.2802823483943939
2020-06-10 01:12:02+00:00,provides update phase keynote evaluating keytruda registered monotherapy combination chemotherapy patients advanced,0.3187370896339416
2020-06-10 00:19:01+00:00,keytruda flunks bladder cancer study,-0.47800013422966
2020-06-10 00:11:01+00:00,bladder cancer study fails meet main goals,-1.0683766603469849
2020-06-11 20:46:02+00:00,optimus maximus est closed covered previously profit corp id stats,0.8058840036392212
2020-06-11 20:31:53+00:00,previously stated announce stashstockparty giveaway,0.0274612382054328
2020-06-11 20:31:22+00:00,lower higher appearances performance close later avg worst later avg worst later avg worst,-0.6859983205795288
2020-06-11 20:25:23+00:00,optimus maximus est closed covered previously profit corp id stats,0.7913484573364258
2020-06-11 20:23:32+00:00,stashstockparty sign,0.9598990678787231
2020-06-11 20:08:00+00:00,,0.8598699569702148
2020-06-11 20:03:30+00:00,stashstockparty folks,0.7359155416488647
2020-06-11 18:24:42+00:00,stashstockparty baby merc som let us,0.375318169593811
2020-06-11 17:50:44+00:00,downgraded valuengine,-1.0064295530319214
2020-06-11 16:13:25+00:00,superstockparty est set alarms stashstockparty,-0.1132758259773254
2020-06-11 15:33:46+00:00,issue dividend,0.0730031877756118
2020-06-11 14:28:16+00:00,optimus maximus est opened corp chance avg avg loss avg id stats,0.880163311958313
2020-06-11 14:24:00+00:00,,0.6612104177474976
2020-06-11 13:55:27+00:00,,-0.9084740877151488
2020-06-11 12:10:55+00:00,uptrend moving average divergence macd crosses signal line view odds money news,0.9489938020706176
2020-06-11 11:13:49+00:00,ex div increased div yld,0.9683725833892822
2020-06-11 10:44:08+00:00,care data phase dont setup bad data bearish care,-1.0635677576065063
2020-06-11 09:53:18+00:00,interest update,0.5268117189407349
2020-06-11 09:52:29+00:00,interest update,0.4380169808864593
2020-06-11 09:22:06+00:00,interest update,0.4380169808864593
2020-06-13 23:20:05+00:00,fda oks hpv vaccine,0.153319850564003
2020-06-13 22:40:23+00:00,fda approves prevention certain hpvrelated headandneckcancers,-0.3597398102283478
2020-06-13 21:58:19+00:00,fda oks hpv vaccine,0.1437909007072448
2020-06-13 21:42:11+00:00,latest hpv news,0.2677736580371856
2020-06-13 21:19:51+00:00,fda oks hpv vaccine,0.153319850564003
2020-06-13 21:17:47+00:00,lowered peer perform wolfe research,-0.87813401222229
2020-06-13 20:38:21+00:00,peak profit expired,0.6875190734863281
2020-06-13 20:30:18+00:00,peaked triggered algo,0.919970154762268
2020-06-13 20:26:17+00:00,view historical performance,0.0985150188207626
2020-06-13 15:08:59+00:00,formulafolio,0.1628884375095367
2020-06-13 14:13:34+00:00,keytruda blockbuster seller drug failed phase test hoped expanding approval treatment common form bladder cancer immunotherapy,-1.0038353204727173
2020-06-13 13:47:27+00:00,fda oks hpv vaccine,0.1437909007072448
2020-06-13 13:46:58+00:00,fda oks hpv vaccine,0.1202854216098785
2020-06-13 13:45:34+00:00,fda oks hpv vaccine,0.153319850564003
2020-06-13 13:18:02+00:00,upcoming event fda set prescription drug fee act pdufa expiring cover event implied move,0.2920418381690979
2020-06-13 12:50:48+00:00,fda approves prevention certain hpvrelated headandneckcancers,-0.4560896754264831
2020-06-14 18:56:26+00:00,capital financial corp,-0.722028374671936
2020-06-14 17:59:03+00:00,gamco et al increases position,0.8799710273742676
2020-06-14 17:00:45+00:00,ship firecracker que titanic theme song,-0.0413742512464523
2020-06-14 16:01:04+00:00,capital financial corp,-0.722028374671936
2020-06-14 15:53:03+00:00,ahead biotech fda decisions cards epizyme evoke ultragenyx,0.0446361042559146
2020-06-14 09:15:47+00:00,rating lowered peer perform wolfe research,-0.90411639213562
2020-06-14 04:01:24+00:00,fda oks hpv vaccine,0.1202854216098785
2020-06-15 21:36:49+00:00,downtrend reaching oversold zone view odds money news,-1.073868989944458
2020-06-15 21:30:53+00:00,falling fast,-1.0126718282699585
2020-06-15 20:31:00+00:00,lower higher appearances performance close later avg worst later avg worst later avg worst,-0.6807560920715332
2020-06-15 20:31:00+00:00,major appearances performance close later avg worst later avg worst later avg worst,-0.921917200088501
2020-06-15 20:31:00+00:00,minor appearances performance close later avg worst later avg worst later avg worst,-0.9430171251296996
2020-06-15 20:29:31+00:00,cancer drug keytruda meet goals study involving bladder cancer patients keytruda already approved types cancer sales billion,1.0012317895889282
2020-06-15 20:18:01+00:00,closes lower row sentiment bearish,-1.0779763460159302
2020-06-15 19:52:04+00:00,let ink dry slippery path atp,0.1799907982349395
2020-06-15 19:52:01+00:00,set fda decision curious way news usually,0.9412318468093872
2020-06-15 19:45:05+00:00,huge variation company common st,-1.0125380754470823
2020-06-15 19:35:18+00:00,gess continue cases virus,-0.1622416228055954
2020-06-15 19:30:05+00:00,huge variation company common st,-1.021389365196228
2020-06-15 19:28:30+00:00,set fda decision curious way news usually svacctsolution money,0.9867388010025024
2020-06-15 19:25:31+00:00,recent technical macd bearish signal line cross plus,-1.0465751886367798
2020-06-15 19:21:06+00:00,delta expiration,-0.0184644982218742
2020-06-15 19:15:05+00:00,huge variation company common st,-1.0124911069869995
2020-06-15 19:02:50+00:00,let ink dry slippery path atp,0.3069656193256378
2020-06-15 18:57:33+00:00,hitting significant underperformer fear big deal exaggerated,-0.8785953521728516
2020-06-15 18:47:41+00:00,pump dump,-0.8612394332885742
2020-06-15 18:45:05+00:00,huge variation company common st,-1.030714988708496
2020-06-15 16:49:27+00:00,similar sessions,-0.8344316482543945
2020-06-15 15:32:25+00:00,,-1.029625415802002
2020-06-15 14:45:18+00:00,early phase pembrolizumab plus radioembolization hcc subjects nct estimated primary completion date,0.0003344230353832
2020-06-15 14:45:05+00:00,huge variation company common st,-1.0120248794555664
2020-06-15 14:44:21+00:00,phase study olaratumab plus pembrolizumab participants advanced metastatic soft tissue sarcoma nct estimated primary completion date,0.3708139061927795
2020-06-15 14:43:24+00:00,phase safety tolerability immunogenicity healthy japanese infants nct estimated primary completion date,0.90582537651062
2020-06-15 14:42:27+00:00,phase msb metastatic locally advanced solid tumors nct estimated primary completion date,0.8155883550643921
2020-06-15 14:41:29+00:00,phase human solid tumors nct estimated primary completion date,0.8830742835998535
2020-06-15 14:40:32+00:00,phase study combinations nct estimated primary completion date,-0.0343617834150791
2020-06-15 14:21:00+00:00,added update fire fund early reflect transaction dividends money fire dgi passiveincome earlyretirement,0.6680814027786255
2020-06-15 12:14:02+00:00,,0.4042727351188659
2020-06-15 12:03:04+00:00,building efforts expanding saferchildbirthcities initiative help endmaternalmortality narrow disparities learn,-0.0643595308065414
2020-06-15 10:56:46+00:00,receives fda approval gardasil,0.1141721680760383
2020-06-15 10:55:59+00:00,receives fda approval gardasil,0.2558662593364715
2020-06-15 09:44:12+00:00,wolfe research lowers peer perform,-0.3891726732254028
2020-06-15 09:40:23+00:00,wolfe research lowers peer perform,-0.17424938082695
2020-06-15 09:38:47+00:00,wolfe research lowers peer perform,-0.17424938082695
2020-06-15 05:46:25+00:00,gardasil receives fda nod expanded cancer,0.0078082904219627
2020-06-15 03:44:09+00:00,gamco et al increases position,0.8799710273742676
2020-06-16 22:40:28+00:00,fda oks keytruda second application based biomarker,0.0147283375263214
2020-06-16 22:06:14+00:00,click latest research,0.325564444065094
2020-06-16 21:38:03+00:00,yr notes yr notes ytm notes ytm notes ytm notes ytm,-0.9345500469207764
2020-06-16 21:32:51+00:00,hands mreck,0.9655413627624512
2020-06-16 21:30:46+00:00,winners,0.9520018100738524
2020-06-16 21:14:54+00:00,fda oks keytruda second application based biomarker,0.0178725346922874
2020-06-16 21:08:25+00:00,fda oks keytruda second application based biomarker,0.0167210735380649
2020-06-16 21:02:54+00:00,waiting,0.2786859273910522
2020-06-16 20:00:08+00:00,stay course imo,0.9663763046264648
2020-06-16 19:46:38+00:00,perhaps close news,0.0260648094117641
2020-06-16 19:45:06+00:00,huge variation company common st,0.5143884420394897
2020-06-16 19:37:32+00:00,present results phase vertis cv patients type diabetes,0.0105826407670974
2020-06-16 19:30:05+00:00,huge variation company common st,0.4941207766532898
2020-06-16 19:20:15+00:00,present results phase vertis cv patients type diabetes,-0.0104704275727272
2020-06-16 19:15:06+00:00,huge variation company common st,0.3856576085090637
2020-06-16 18:55:28+00:00,downtrend moving average divergence macd crosses signal line view odds money news,-1.0743948221206665
2020-06-16 18:45:06+00:00,huge variation company common st,0.3772499859333038
2020-06-16 18:30:06+00:00,huge variation company common st,0.5816917419433594
2020-06-16 18:17:39+00:00,dip,0.9800909757614136
2020-06-16 18:15:06+00:00,huge variation company common st,0.5011333227157593
2020-06-16 17:58:50+00:00,dip,0.9836968183517456
2020-06-16 17:52:18+00:00,thought cancer treatment,-0.4138332605361938
2020-06-16 17:50:59+00:00,expected,-0.3124161064624786
2020-06-16 17:45:05+00:00,huge variation company common st,0.5203704833984375
2020-06-16 17:30:06+00:00,huge variation company common st,0.533031702041626
2020-06-16 17:28:04+00:00,sglt inhibitor steglatrotm ertugliflozin meets primary endpoint vertis cv,-0.0730490237474441
2020-06-16 17:22:55+00:00,jul,0.1443413347005844
2020-06-16 17:20:23+00:00,click latest research,0.3176840543746948
2020-06-16 17:15:06+00:00,huge variation company common st,0.3771114349365234
2020-06-16 16:45:06+00:00,huge variation company common st,0.5613536834716797
2020-06-16 16:44:59+00:00,bought contract,0.944632649421692
2020-06-16 16:03:26+00:00,unusual sweep opened premium oi,-0.2593541443347931
2020-06-16 15:59:07+00:00,unusual sweep opened premium oi,-0.7212380170822144
2020-06-16 15:46:59+00:00,phase study zoledronic acid pravastatin lonafarnib patients progeria nct estimated primary completion date,-0.0233194418251514
2020-06-16 15:46:00+00:00,phase phase neoadjuvant pembrolizumab combination gemcitabine therapy ineligible uc subjects nct estimated primary completion date,-0.0758864879608154
2020-06-16 15:45:01+00:00,phase pembrolizumab locally delivered radiation therapy treatment metastatic esophageal cancers nct estimated primary completion date,-0.0729965046048164
2020-06-16 15:44:03+00:00,phase study cy pembrolizumab gvax sbrt patients locally advanced pancreatic cancer nct estimated primary completion date,0.0317372605204582
2020-06-16 15:43:04+00:00,phase study azacitidine combination pembrolizumab relapsed refractory acute myeloid leukemia aml patients newly diagnosed older aml patients nct estimated primary completion date,0.098348282277584
2020-06-16 15:42:06+00:00,phase study pembrolizumab combination nct estimated primary completion date,0.0064963065087795
2020-06-16 15:41:07+00:00,phase safety tolerability efficacy doxorubicin pembrolizumab sarcoma nct estimated primary completion date,0.3521390259265899
2020-06-16 15:18:56+00:00,poor technical analysis score ta score categories score neutral moving average score poor score neutral,-1.0545660257339478
2020-06-16 14:45:03+00:00,recent technical macd bearish centerline cross plus,-1.0456761121749878
2020-06-16 14:42:08+00:00,showstopper discord stop,-1.005721926689148
2020-06-16 14:37:29+00:00,paid,0.5880482196807861
2020-06-16 14:25:54+00:00,files form,-0.0812928080558776
2020-06-16 13:43:01+00:00,optimus maximus et opened corp chance avg avg loss avg id stats,0.8775796890258789
2020-06-16 13:34:03+00:00,brand name decadron least answered question part let matters,-0.3934382796287536
2020-06-16 13:11:37+00:00,form prospectus rule filed sec,-0.0819078683853149
2020-06-16 13:09:35+00:00,form prospectus rule filed sec,-0.0819078683853149
2020-06-16 12:39:07+00:00,pre announces proposals second cohort safer childbirth cities expanding maternal health across us cities si,0.3980063498020172
2020-06-16 10:20:58+00:00,fail break proven fatal,-1.0607348680496216
2020-06-16 07:37:21+00:00,downgraded peer perform wolfe research,-1.0045030117034912
2020-06-16 04:15:40+00:00,hoping range,0.2946541011333465
2020-06-16 03:00:39+00:00,oi range expiration putcallratio,0.967025876045227
2020-06-16 01:58:31+00:00,announces proposals second cohort safer childbirth cities expanding maternal health across us cities,0.0573954284191131
2020-06-16 00:20:50+00:00,jun straddle implies move jun fda set prescription drug fee act pdufa,0.1539831310510635
2020-06-17 23:38:21+00:00,sense serious nash partnered ngm prob capture big nash,-0.3943122923374176
2020-06-17 22:57:47+00:00,animal health completes acquisition quantified ag registered,0.2417146861553192
2020-06-17 22:36:24+00:00,click latest news,0.3487266898155212
2020-06-17 21:21:13+00:00,fda approves keytruda regardless tumor type tumor mutational,0.1438224911689758
2020-06-17 20:41:15+00:00,animal health completes acquisition quantified ag registered,0.1973229795694351
2020-06-17 20:33:05+00:00,click latest news,0.34400075674057
2020-06-17 20:30:52+00:00,dark cloud cover appearances close later avg sd worst later avg sd worst later avg sd worst,-1.0091986656188965
2020-06-17 18:43:51+00:00,hearing weak mlb news,-1.0729999542236328
2020-06-17 18:22:47+00:00,loading boat range bots,0.7606052160263062
2020-06-17 18:15:56+00:00,super smart design deserve premium,0.99018657207489
2020-06-17 17:49:24+00:00,venturi wealth management,0.1779105216264724
2020-06-17 17:49:16+00:00,capitalism change recently,0.3672540485858917
2020-06-17 17:09:09+00:00,fda approves second keytruda registered pembrolizumab regardless tumor type,0.0487544909119606
2020-06-17 16:34:02+00:00,least ask ken frazier,-0.2135026305913925
2020-06-17 16:08:58+00:00,billion debt offering,0.0361474528908729
2020-06-17 15:54:20+00:00,debt offering par,0.050540667027235
2020-06-17 15:49:59+00:00,witnesses hearing former hhs sec mike leavitt gerberding hearing examine lessons pandemic reminder current pandemic raging,-0.0512647181749343
2020-06-17 15:42:07+00:00,downtrend staying oversold zone view odds money news,-1.075412392616272
2020-06-17 15:30:15+00:00,optimus et bought opened corp chance avg avg loss avg id stats,0.8566842079162598
2020-06-17 14:58:03+00:00,happy news vaccineswork approves prevent head neck cancer reason rus,0.9802229404449464
2020-06-17 14:23:02+00:00,expansion moot company outstanding,0.948078989982605
2020-06-17 13:41:12+00:00,optimus maximus et opened corp chance avg avg loss avg id stats,0.8795170783996582
2020-06-17 13:32:50+00:00,optimus maximus et closed covered previously loss corp id stats,-1.0774375200271606
2020-06-17 12:48:07+00:00,fda approved keytruda monotherapy treatment adult pediatric patients unresectable metastatic tumor mutational solid tumors progressed prior treatment,0.9210308790206908
2020-06-17 12:34:24+00:00,billion public offering series senior unsecured notes,0.1552626490592956
2020-06-17 12:25:07+00:00,yes searching found trademark,0.2028358280658722
2020-06-17 12:12:26+00:00,pre debt offering par sa,0.2437860816717147
2020-06-17 12:12:20+00:00,pre fda oks keytruda second application based biomarker sa,0.1441584527492523
2020-06-17 11:37:04+00:00,sglt inhibitor steglatrotm ertugliflozin meets primary endpoint vertis cv patients type diabetes atherosclerotic cardiovascular disease,-0.0346265509724617
2020-06-17 11:34:16+00:00,fda approves second keytruda,0.0304619818925857
2020-06-17 11:23:16+00:00,fda approves second keytruda registered pembrolizumab regardless tumor type,0.0487544909119606
2020-06-17 11:08:16+00:00,fda approves second keytruda,0.0398697145283222
2020-06-17 11:08:01+00:00,happy news vaccineswork approves prevent head neck cancer reason rush pre teens doctor vaccinated save cancer unemployed oncologist thing,0.9838813543319702
2020-06-17 10:55:20+00:00,bond offering,0.0098437368869781
2020-06-17 10:50:51+00:00,commitment helping expand cancer patients continues learn latest fda approval,0.7116070985794067
2020-06-17 10:49:43+00:00,fda approves second keytruda regardless tumor type,0.0399284437298774
2020-06-17 10:49:39+00:00,fda approves second keytruda registered regardless tumor type,0.0379395671188831
2020-06-17 10:49:12+00:00,click latest news,0.3904753923416137
2020-06-17 10:48:26+00:00,fda approves second keytruda,0.0470847561955452
2020-06-17 10:47:57+00:00,fda approves second keytruda registered regardless tumor type,0.0379395671188831
2020-06-17 10:46:32+00:00,fda approves second keytruda registered pembrolizumab regardless tumor type,0.0599551871418952
2020-06-17 10:46:32+00:00,billion debt offering,0.0361474528908729
2020-06-17 10:44:39+00:00,debt offering par,0.0454384908080101
2020-06-17 10:43:57+00:00,debt offering par,0.0454384908080101
2020-06-17 10:42:32+00:00,debt offering par,0.0768396854400634
2020-06-17 09:48:57+00:00,form fwp filing securities act rules writing prospectuses filed sec,0.5743820667266846
2020-06-17 05:46:52+00:00,quarantine propecia,0.1579214930534362
2020-06-17 04:19:17+00:00,quarantine propecia,0.2063888609409332
2020-06-17 02:18:41+00:00,candy continue,0.9623426198959352
2020-06-17 02:00:06+00:00,huge variation company common st,0.6083700656890869
2020-06-17 01:18:58+00:00,flow update optionsflow healthcare,0.854638934135437
2020-06-17 01:06:58+00:00,fda oks keytruda second application based biomarker,0.0123783536255359
2020-06-18 22:01:02+00:00,keytruda nabs fda nod regardless tumor type keytruda starting trend cancer oncology,-0.0145369656383991
2020-06-18 21:48:37+00:00,newsars treatment ethical question appropriate continue clinical include dexamethasone standard treatment gave eua remdesivir data safety monitoring board announce saving hospitalization,0.6324838399887085
2020-06-18 20:42:58+00:00,outside coronavirus pandemic continuing development plans cancer drug keytruda keytruda easily important product facing rivalry bristol myers squibb bmy opdivo,0.8490883111953735
2020-06-18 20:03:42+00:00,downtrend stays oversold zone view odds money news,-1.0756648778915403
2020-06-18 18:52:36+00:00,analysts appealing opportunity drug manufacturing combination wide li,0.944139003753662
2020-06-18 17:44:43+00:00,shit,-1.0488128662109375
2020-06-18 17:20:05+00:00,analysts appealing opportunity drug manufacturing combination wide lineup drugs pipeline drugs ensure returns capital long term,0.979516625404358
2020-06-18 15:14:05+00:00,bought supply disruptions credit tightening bear play hands big pharma pushes capitalized pipeline small cap bios consolidate need anymore keytruda juggernaut,0.9265068769454956
2020-06-18 14:20:27+00:00,sglt inhibitor steglatrotm ertugliflozin meets primary endpoint vertis cv pati,-0.0773210600018501
2020-06-18 13:34:48+00:00,optimus maximus et closed covered previously profit corp id stats,0.797437310218811
2020-06-18 12:56:39+00:00,human talked canadian infectious disease expert gary kobinger leading mind development ebola vaccine lessons hurdles early clinical vaccine research,0.332467645406723
2020-06-18 11:12:18+00:00,animal health completes acquisition quantified ag registered,0.1973229795694351
2020-06-18 08:58:07+00:00,fda approves second keytruda registered pembrolizumab regardless tumor type,0.1285424083471298
2020-06-18 08:52:28+00:00,billion debtoffering,-0.0694218575954437
2020-06-18 06:31:29+00:00,entry change recently,0.8974488973617554
2020-06-18 03:15:54+00:00,billion debt offering href,-0.0181706920266151
2020-06-18 03:15:46+00:00,billion debt offering,0.0273826867341995
2020-06-18 03:10:12+00:00,open interest update optionsflow,0.4729502201080322
2020-06-18 01:00:36+00:00,sizable quote changes change recently,0.4213838577270508
2020-06-19 23:39:49+00:00,ridgeback partnered progressing eidd phase patients,-0.062692642211914
2020-06-19 23:22:07+00:00,ridgeback partnered progressing eidd phase patients,-0.0308617427945137
2020-06-19 21:30:50+00:00,shooting roof increase,0.9853668212890624
2020-06-19 20:47:31+00:00,,0.0299751423299312
2020-06-19 20:20:59+00:00,star appearances close later avg sd worst later avg sd worst later avg sd worst,-0.8146243095397949
2020-06-19 20:00:29+00:00,optimus et closed profit corp id stats,0.6189471483230591
2020-06-19 19:54:20+00:00,long hope hit soon,0.9153352975845336
2020-06-19 18:25:58+00:00,receives consensus rating analysts,0.8996407985687256
2020-06-19 16:42:55+00:00,deal,0.4493983685970306
2020-06-19 16:35:19+00:00,deal let goo,0.8947217464447021
2020-06-19 16:05:14+00:00,ridgeback ready start tests covid drug,0.2566014528274536
2020-06-19 15:56:37+00:00,completes acquisition themis,0.442325085401535
2020-06-19 15:54:01+00:00,withdraws keytruda application europe esophageal cancer,-0.9227982759475708
2020-06-19 15:53:18+00:00,latest news,0.3450494706630707
2020-06-19 15:43:27+00:00,rape case table,-1.055367350578308
2020-06-19 15:36:36+00:00,imo pps ready kick,0.9831130504608154
2020-06-19 14:23:34+00:00,ring hopefully oral antiviral tour bballcrazy,0.4308922588825226
2020-06-19 13:18:13+00:00,completes themis coronavirus vaccine tap,0.9259803295135498
2020-06-19 13:07:35+00:00,completes acquisition themis,0.442325085401535
2020-06-19 12:59:39+00:00,completes themis coronavirus vaccine tap,0.9138413667678832
2020-06-19 12:53:59+00:00,completes themis coronavirus vaccine tap,0.9138413667678832
2020-06-19 12:51:39+00:00,latest news,0.3653012812137604
2020-06-19 12:43:34+00:00,directional bias report click details,-0.7779198884963989
2020-06-19 12:41:03+00:00,report click,0.2802823483943939
2020-06-19 12:29:59+00:00,completes acquisition themis,0.3244211077690124
2020-06-19 10:12:47+00:00,large drop interest,-1.0776875019073486
2020-06-19 10:01:35+00:00,uptrend leaves oversold zone view odds money news,0.9103636741638184
2020-06-19 09:24:59+00:00,large drop interest,-1.072917342185974
2020-06-19 09:24:12+00:00,large drop interest,-1.072917342185974
2020-06-19 09:22:45+00:00,large drop interest,-1.072917342185974
2020-06-19 06:59:59+00:00,form prospectus rule filed sec,-0.0819078683853149
2020-06-19 06:50:19+00:00,heterotrimeric receptors taste function thus targeting lead significant taste effects seen gefapixant key tolerability issue asset,-0.9532315731048584
2020-06-20 20:30:39+00:00,significant movement change recently,0.883901834487915
2020-06-20 16:47:36+00:00,max pain maturity,-0.0561835765838623
2020-06-20 15:07:02+00:00,gap scanner identified beautiful reversal fibs,0.9866418838500975
2020-06-20 14:12:57+00:00,gap scanner identified beautiful reversal fibs identified probability early,0.9765303134918212
2020-06-20 11:12:41+00:00,well reckon noise abt raising ab levels thing medium term aka immunity stretch goal us trendy landing zones novel rx endpts biomarkers formerly known phii data,0.9065344333648682
2020-06-20 10:18:50+00:00,uptrend leaves oversold zone view odds,0.9415057897567748
2020-06-20 10:16:00+00:00,uptrend leaves oversold zone view odds money news,0.9103636741638184
2020-06-20 07:38:53+00:00,substantial changes change recently,0.7925832271575928
2020-06-20 02:45:44+00:00,power open interest update optionsflow,0.7075719833374023
2020-06-21 22:21:00+00:00,happy decent chunk oncology specialist,0.9666714668273926
2020-06-21 21:46:03+00:00,international biotechnology trust million position,0.1625210046768188
2020-06-21 21:23:41+00:00,reasonable changes change recently,0.9271970987319946
2020-06-21 20:55:48+00:00,happy decent chunk oncology specialist,0.9717330932617188
2020-06-21 20:13:34+00:00,surprised er dabble change recently,-0.5558052062988281
2020-06-21 19:01:04+00:00,argi services boosts,0.641494631767273
2020-06-21 18:41:03+00:00,pin oak advisors position,0.2043183743953704
2020-06-21 17:56:03+00:00,argi services boosts,0.641494631767273
2020-06-21 14:49:33+00:00,thank upcoming fda news rarely news observed positive divergent action template cc,0.949349045753479
2020-06-21 14:12:51+00:00,substantial changes change recently,0.7925832271575928
2020-06-21 09:25:24+00:00,uptrend peaks leaves oversold zone view odds,0.946029543876648
2020-06-21 09:24:50+00:00,uptrend peaks leaves oversold zone view odds money news,0.9394015073776244
2020-06-21 08:18:20+00:00,long targets targets ilmtraders dtilmtraders mark,0.6024507284164429
2020-06-21 04:26:29+00:00,long targets targets ilmtraders dtilmtraders marketwatch,-0.2895959913730621
2020-06-21 02:51:26+00:00,change recently,0.8443390130996704
2020-06-22 18:31:49+00:00,voloridge management,-0.6920636892318726
2020-06-22 16:10:29+00:00,keytruda approved china treatment patients locally advanced metastatic,0.6372735500335693
2020-06-22 15:40:48+00:00,sep sweep near bid oi earnings open est ref,0.6262693405151367
2020-06-22 15:40:38+00:00,sep sweep near bid oi earnings open est ref,0.5415831804275513
2020-06-22 15:09:02+00:00,keytruda fda clearance regardless tumor type oncology pharma,-0.0038312822580337
2020-06-22 15:07:11+00:00,virus scale us,-0.0603714771568775
2020-06-22 14:50:13+00:00,sep bid oi earnings open est ref,0.1114545688033104
2020-06-22 14:07:27+00:00,announces investigational valent pneumococcal conjugate vaccine met safety immunogenicity objectives initial phase studies adults,0.0936173349618911
2020-06-22 13:59:16+00:00,keytruda approved china across different cancer types,-0.0331970602273941
2020-06-22 13:32:42+00:00,keytruda china approval analyst applauds advantage,0.8287279605865479
2020-06-22 13:18:34+00:00,uptrend leaves oversold zone view odds,0.9415057897567748
2020-06-22 13:14:21+00:00,uptrend leaves oversold zone view odds money news,0.9103636741638184
2020-06-22 13:11:07+00:00,moot,0.0335039347410202
2020-06-22 12:55:02+00:00,latest pneumococcal disease news isppd,0.1625703275203704
2020-06-22 12:47:27+00:00,announces investigational valent pneumococcal conjugate vaccine met safety,0.0364885628223419
2020-06-22 12:45:45+00:00,yield accelerating dividend growth potential undervalued rare opportunity latest udgsow pick,0.9981409311294556
2020-06-22 12:35:43+00:00,announces investigational valent pneumococcal conjugate vaccine met safety immunogenicity objectives initial phase studies adults,0.0618467442691326
2020-06-22 12:33:27+00:00,keytruda approved china treatment patients locally advanced metastatic,0.6284403800964355
2020-06-22 11:55:35+00:00,keytruda registered pembrolizumab approved china treatment patients locally advanced metastatic esophageal squamous cell carcinoma whose tumors express cps,0.3075749278068542
2020-06-22 11:54:53+00:00,pre pneumonia vaccine successful studies sa,0.7273392677307129
2020-06-22 11:30:08+00:00,learn newest update esophagealcancer,0.1624110490083694
2020-06-22 11:20:03+00:00,keytruda registered pembrolizumab approved china treatment patients locally ad,0.2990288734436035
2020-06-22 11:16:41+00:00,announces investigational valent pneumococcal conjugate vaccine met safety,0.0412325672805309
2020-06-22 11:09:19+00:00,pneumonia vaccine successful studies,0.9403239488601683
2020-06-22 11:00:07+00:00,pneumonia vaccine successful studies,0.958843231201172
2020-06-22 10:51:04+00:00,announces investigational valent pneumococcal conjugate vaccine met safety immunogenicity objectives initial phase studies adults,0.1144994720816612
2020-06-22 10:48:09+00:00,met safety immunogenicity objectives phase studies,0.0889151245355606
2020-06-22 10:47:43+00:00,latest pneumococcal disease news isppd,0.119779996573925
2020-06-22 10:47:19+00:00,keytruda ok china line esophageal cancer,0.6576042175292969
2020-06-22 10:41:02+00:00,keytruda ok china line esophageal cancer,0.735535740852356
2020-06-22 10:40:35+00:00,keytruda ok china line esophageal cancer,0.6576042175292969
2020-06-22 10:33:11+00:00,learn newest update esophagealcancer,0.1455101519823074
2020-06-22 10:33:09+00:00,keytruda approved china treatment escc,0.651542067527771
2020-06-22 10:32:26+00:00,keytruda pembrolizumab approved china treatment patients locally advanced metastatic esophageal squamous cell carcinoma whose tumors express cps,0.2427781969308853
2020-06-22 10:31:04+00:00,keytruda registered approved china treatment patients locally advanced metastatic esophageal squamous cell carcinoma whose tumors express,0.5363994836807251
2020-06-22 03:14:26+00:00,bear burger medium rare mushroom swiss please change recently,0.6072205305099487
2020-06-22 00:52:20+00:00,,0.014295183122158
2020-06-23 21:46:32+00:00,jason fieber tipping biggest us pharma undervalued imo along healthcare pharma atm dividend practically prints money sale,0.9615921974182128
2020-06-23 20:39:12+00:00,jul atm implied volatility straddle implies move earnings jul bmo,-1.0613479614257812
2020-06-23 20:37:56+00:00,sorry date respect,-1.0542826652526855
2020-06-23 20:34:51+00:00,shot interest mess,-0.8856519460678101
2020-06-23 19:56:52+00:00,carret asset management trims stake,0.0688895136117935
2020-06-23 19:52:22+00:00,active,0.8520083427429199
2020-06-23 19:18:04+00:00,active,0.7616342306137085
2020-06-23 18:15:00+00:00,files form,-0.1102470457553863
2020-06-23 16:43:18+00:00,gerberding vaccines need higher bar safety,0.7883201837539673
2020-06-23 16:10:24+00:00,ms ridgeback oral antiviral candidate eidd covid blockbuster potential successful covid patients oral initial diagnosis reduce disease severity risk reiterate ow rating,0.9810842275619508
2020-06-23 15:55:02+00:00,due uptick party imo,0.996381402015686
2020-06-23 14:59:30+00:00,build public confidence vaccines gerberding transparency safety assessments involves cdc acip fda scientific organizations safety monitored,0.1533182710409164
2020-06-23 14:54:06+00:00,gerberding large vaccines manufacturers almost capacity need build done partnership platform approach partnership model remove incentives pharma biotech innovate,0.9774839878082277
2020-06-23 14:46:58+00:00,update entered discussed stopped,0.6145092248916626
2020-06-23 14:44:14+00:00,gerberding sustained national leadership level national security council critical sustained budgetary ending cycle complacency crisis cdc needs function apolitical environment pandemic,0.8308205604553223
2020-06-23 14:42:37+00:00,gapped favor earnings tighten stop position,-1.0722547769546509
2020-06-23 14:40:43+00:00,gerberding vaccines need higher bar safety sacrifice safety sake speed need trust vaccine safe pandemic,0.9813687801361084
2020-06-23 14:39:34+00:00,former cdc gerberding virus incredibly transmissible causes harm serious morbidity mortality continue spread nowhere near end mitigation phase crisis pandemic,0.8110659122467041
2020-06-23 14:25:12+00:00,former bush admin officials hhs gerberding cdc former gop sen maj leader,-0.0144324451684951
2020-06-23 14:13:52+00:00,covid antiviral candidate underappreciated morgan stanley,0.6160190105438232
2020-06-23 14:10:36+00:00,subject witnesses gerberding pandemic,-0.0486955866217613
2020-06-23 13:57:49+00:00,wait collab announcement,0.5264389514923096
2020-06-23 13:50:58+00:00,covid antiviral candidate underappreciated morgan stanley,0.6786994934082031
2020-06-23 13:45:37+00:00,covid antiviral candidate underappreciated morgan stanley,0.8046301603317261
2020-06-23 13:45:28+00:00,face,0.4239530265331268
2020-06-23 13:31:34+00:00,eps expected quarter,0.1335571259260177
2020-06-23 13:31:30+00:00,zacks analysts anticipate earnings,0.3153860867023468
2020-06-23 13:29:42+00:00,eps expected quarter,0.1335571259260177
2020-06-23 13:29:10+00:00,eps expected quarter,0.1979430168867111
2020-06-23 11:57:12+00:00,former bush admin officials hhs gerberding cdc former gop sen maj leader talking lessons learned pandemic planning pandemic,0.000885471701622
2020-06-23 11:34:55+00:00,news around corner potential collab,0.1596170961856842
2020-06-23 11:28:21+00:00,uptrend recovers oversold zone view odds money news,0.9553284645080566
2020-06-23 11:20:43+00:00,bioinvent enroll patient solid tumor,0.8569440841674805
2020-06-23 09:20:37+00:00,bioinvent enrolls patient phase iia bi combination keytruda registered,0.1478231251239776
2020-06-23 09:06:52+00:00,bioinvent enrolls patient phase iia bi combination keytruda registered treatment patients solid tumors,0.923636555671692
2020-06-23 08:25:18+00:00,keytruda registered pembrolizumab approved china treatment patients locally advanced metastatic esophagealsquamouscellcarcinoma whose tumors express cps,0.2234597951173782
2020-06-23 02:52:01+00:00,advances along broad phiii front aimed carving vaccine franchise ambush lay wait,0.1094306632876396
2020-06-23 00:37:40+00:00,major changes,0.3438725471496582
2020-06-23 00:27:23+00:00,brokerages set target,0.1006430014967918
2020-06-24 23:32:58+00:00,announces fda approved keytruda recurrent metastatic cutaneous squamous cell,0.0206799432635307
2020-06-24 22:54:16+00:00,fda oks keytruda type skin cancer,-0.0767517685890197
2020-06-24 21:46:16+00:00,fda approves keytruda registered pembrolizumab treatment patients recurrent metastatic cu,0.1434925943613052
2020-06-24 21:33:42+00:00,announcing latest oncology fda approval advanced cutaneous squamous cell carcinoma cscc skincancer,0.7031922340393066
2020-06-24 21:33:16+00:00,fda approves keytruda registered treatment patients recurrent metastatic cutaneous squamous cell carcinoma cu,-0.0615085363388061
2020-06-24 21:32:47+00:00,keytruda approved fda cscc curable surgery radiation,0.2744728028774261
2020-06-24 20:27:57+00:00,files form financial statements exhibits events,-0.1056424528360366
2020-06-24 20:22:27+00:00,form press news current report recently sec filed,-0.0137268528342247
2020-06-24 20:06:57+00:00,fda oks keytruda type skin cancer,-0.0529520809650421
2020-06-24 19:50:19+00:00,bayer pay billion settle bulk roundup weedkiller cancer lawsuits,-0.0591161176562309
2020-06-24 19:08:05+00:00,excellent deal access neuro disease drugs pens million yumanity pact nabbing neuro hopefuls process als neurodegenerativedisease neurodegenerative,1.0044585466384888
2020-06-24 18:16:07+00:00,added portfolio undervalued,0.9571349620819092
2020-06-24 17:35:59+00:00,done careful,-1.0019097328186035
2020-06-24 17:35:49+00:00,neuroscience alzheimer drug plans unraveled deals past ye,-0.1241099536418914
2020-06-24 16:38:46+00:00,done careful,-1.0270806550979614
2020-06-24 16:22:11+00:00,neuroscience deal tapping yumanity brain drugs,-0.1230956614017486
2020-06-24 16:20:59+00:00,neuroscience alzheimer drug plans unraveled deals past however help keep open,0.5085881948471069
2020-06-24 14:27:26+00:00,gerberding opportunity improvement terms leadership stockpile moved,0.9699898958206176
2020-06-24 14:27:09+00:00,gerberding clear sns asset operate standalone entity prepared meet,-0.103785440325737
2020-06-24 14:24:10+00:00,gerberding strategic national stockpile budget process needs improvement impossible budget clarity supposed accomplish often tail wags dog pandemic,0.7610265016555786
2020-06-24 14:23:39+00:00,gerberding opportunity improvement terms leadership stockpile moved cdc dhs cdc hhs fema involved current deployment consistent leadership clarity delivery,0.9280195236206056
2020-06-24 14:23:03+00:00,gerberding clear sns asset operate standalone entity prepared meet needs augment states health care settings already inconsistency led approach procurement decisions,0.1242569014430046
2020-06-24 14:22:27+00:00,senate hsgac hearing former cdc gerberding debates inconsistencies whether sns conceived deployed locally national crisis need meet entire country,-0.1521001458168029
2020-06-24 13:33:40+00:00,upgrades,0.9738218784332277
2020-06-24 13:18:45+00:00,yumanity partner neurodegenerative disease drug development,-0.0495693758130073
2020-06-24 12:46:52+00:00,underscores commitment hiv data analyses presented aids,0.0777647346258163
2020-06-24 12:01:23+00:00,yumanity partner neurodegenerative disease drug development,-0.0317745432257652
2020-06-24 11:33:43+00:00,uptrend peaks leaves oversold zone view odds money news,0.9394015073776244
2020-06-24 11:24:55+00:00,yumanity therapeutics deal aimed developing medicines neurodegenerative disease,0.1633602082729339
2020-06-24 11:22:15+00:00,yumanity therapeutics deal aimed developing medicines neurodegenerative disease,0.1728568375110626
2020-06-24 11:04:03+00:00,underscores commitment hiv data analyses presented aids virtual,0.086992472410202
2020-06-24 11:03:18+00:00,underscores commitment hiv data analyses presented aids virtual,0.0942564085125923
2020-06-24 10:55:20+00:00,underscores commitment hiv data analyses presented aids virtual,0.1016530245542526
2020-06-24 10:48:35+00:00,committed helping address unmet needs hiv community along latest data aids virtual conference,0.4970289170742035
2020-06-24 09:00:07+00:00,rating reaffirmed mizuho,0.883885383605957
2020-06-24 08:59:39+00:00,rating reaffirmed mizuho,0.883885383605957
2020-06-24 08:24:59+00:00,rating reaffirmed morgan stanley,0.8767925500869751
2020-06-24 08:22:13+00:00,morgan stanley reaffirms rating,0.8714958429336548
2020-06-24 08:21:41+00:00,rating reaffirmed morgan stanley,0.8767925500869751
2020-06-24 08:21:41+00:00,rating reaffirmed mizuho,0.883885383605957
2020-06-24 08:21:39+00:00,rating reaffirmed mizuho,0.883885383605957
2020-06-24 07:35:26+00:00,morgan stanley reaffirms rating,0.8824141025543213
2020-06-24 04:31:53+00:00,lake point wealth management increases,0.900913953781128
2020-06-24 02:51:52+00:00,integrated wealth concepts raises position,0.7689089775085449
2020-06-25 23:18:26+00:00,expecting af honest hype finishes happy bought late regret hopefully collab,0.9454632997512816
2020-06-25 17:44:30+00:00,company profile fundamental technical analysis score update fa score ta score,0.0461053028702735
2020-06-25 17:26:37+00:00,stuff man keep mind dominate often involves rid competitors always though runor news,0.9898818731307985
2020-06-25 16:50:35+00:00,fdx advisors increases,0.8771039247512817
2020-06-25 15:16:16+00:00,little action speak,-0.5381656885147095
2020-06-25 13:39:33+00:00,merger gunna us motherland phil,0.2984726130962372
2020-06-25 13:03:02+00:00,idea key resistance key test target,0.5887761116027832
2020-06-25 12:44:13+00:00,reports fda approves keytruda treatment patients recurrent metastatic cutaneous squamous cell carcinoma,0.056876853108406
2020-06-25 12:27:27+00:00,pre fda oks keytruda type skin cancer sa,-0.8766944408416748
2020-06-25 12:20:32+00:00,pre fda oks keytruda type skin cancer sa,-0.7876158952713013
2020-06-25 12:14:24+00:00,reports fda approves keytruda treatment patients recurrent metastatic cutaneous squamous cell carcinoma curable surgery radiation,-0.0643775463104248
2020-06-25 11:37:13+00:00,confident guys,0.8302218914031982
2020-06-25 10:18:48+00:00,uptrend recovers oversold zone view odds,0.9635707139968872
2020-06-25 10:16:58+00:00,uptrend recovers oversold zone view odds money news,0.9553284645080566
2020-06-25 09:44:46+00:00,fda approves keytruda registered pembrolizumab treatment patients recurrent metastatic cutaneoussquamouscellcarcinoma cscc curable surgery radiation,-0.2124303430318832
2020-06-25 08:15:59+00:00,zacks analysts expect announce sales billion,0.0880366861820221
2020-06-25 08:15:12+00:00,billion sales expected quarter,0.2592760026454925
2020-06-25 08:14:11+00:00,zacks analysts expect announce sales billion,0.0880366861820221
2020-06-25 08:11:42+00:00,zacks analysts expect announce sales billion,0.0880366861820221
2020-06-25 07:21:30+00:00,rating reiterated morgan stanley,0.2557893991470337
2020-06-25 07:21:24+00:00,rating reiterated morgan stanley,0.2557893991470337
2020-06-25 06:49:45+00:00,rating reiterated morgan stanley,0.2557893991470337
2020-06-25 06:48:29+00:00,rating reiterated morgan stanley,0.2557893991470337
2020-06-25 04:00:30+00:00,fda approves keytruda registered treatment patients recurrent metastatic cutaneous squamous cell carcinoma,-0.0008810609579086
2020-06-25 03:49:01+00:00,burned alzheimer failures cautious turns startup biotech preclinical neuro programs,-1.0419259071350098
2020-06-25 03:18:38+00:00,interesting closed billion public offering,0.930832862854004
2020-06-25 03:15:26+00:00,fda oks keytruda type skin cancer,-0.0055097453296184
2020-06-25 02:49:35+00:00,given average recommendation brokerages,0.8635251522064209
2020-06-25 02:16:10+00:00,interesting closed billion public offering,0.9336049556732178
2020-06-25 00:45:26+00:00,fda oks keytruda type skin cancer,-0.0529520809650421
2020-06-25 00:30:17+00:00,yumanity entered collab focused therapies neurodegenerative diseases gained exclusive preclinical pipeline programs als ftd yumanity received undisclosed milestones,0.7152880430221558
2020-06-26 23:33:32+00:00,collab announcement happens seen york minute help israel,0.7775903940200806
2020-06-26 19:40:03+00:00,,-1.064060091972351
2020-06-26 19:18:59+00:00,company profile fundamental technical analysis score update fa score ta score,0.0461053028702735
2020-06-26 19:08:27+00:00,bought vaccines children manufacturer small operations every across,0.1092410907149314
2020-06-26 19:01:27+00:00,bought vaccines children manufacturer small operations every across world quality companies stick around pay dividends,0.9498111009597778
2020-06-26 17:20:12+00:00,changing lives wow,0.5376825332641602
2020-06-26 16:10:50+00:00,,-0.0663584768772125
2020-06-26 15:48:59+00:00,,-0.0573767088353633
2020-06-26 14:44:55+00:00,tank eyes,0.7184877395629883
2020-06-26 14:17:00+00:00,results studies experimental pneumococcal conjugate vaccine help su,0.3467922508716583
2020-06-26 14:08:02+00:00,pens yumanity pact nabbing neuro hopefuls process collaboration beef neurology pipeline company behind alzheimer program,-0.0607805699110031
2020-06-26 12:29:12+00:00,uptrend peaks leaves oversold zone view odds money news,0.9394015073776244
2020-06-26 12:25:36+00:00,earns rating mizuho,0.8761838674545288
2020-06-26 11:48:26+00:00,highly overlooked ktov,-0.8545076847076416
2020-06-26 11:10:36+00:00,earns rating mizuho,0.9276423454284668
2020-06-26 09:23:25+00:00,receives rating morgan stanley,0.8412171602249146
2020-06-26 09:20:36+00:00,receives rating morgan stanley,0.871347188949585
2020-06-26 04:03:41+00:00,jul straddle implies move jun pdufa,0.3429857492446899
2020-06-26 03:52:11+00:00,dividend practically prints money,0.0864992439746856
2020-06-26 03:49:00+00:00,fda oks heavyweight keytruda cancer niche triggering title fight street brawlers regeneron,-0.7618710994720459
2020-06-26 03:23:27+00:00,entirely pr play longs expect collab announcement long hope jumps fades,0.7907160520553589
2020-06-26 02:55:59+00:00,bought baby dividendinvesting,0.9485187530517578
2020-06-27 18:33:47+00:00,keytruda piece puzzle shell royalties every buyout almost easier,0.2131499052047729
2020-06-27 14:37:11+00:00,depends atopic derm well prove pivotal clearly highest upside drugs valued successful gobble,0.966341495513916
2020-06-27 13:10:28+00:00,jun peak progress,0.8915084600448608
2020-06-27 13:06:27+00:00,jun jun peak progress,0.8529850244522095
2020-06-27 12:58:27+00:00,peak profit expired,0.6875190734863281
2020-06-27 12:54:25+00:00,jul,0.8937970399856567
2020-06-27 12:50:25+00:00,performance algo based,0.3085912764072418
2020-06-27 12:46:25+00:00,peaked triggered algo,0.9204837083816528
2020-06-27 12:42:23+00:00,view historical performance,0.0985150188207626
2020-06-27 11:31:29+00:00,upcoming event pdufa expiring cover event implied move,0.2227286547422409
2020-06-27 11:23:13+00:00,soothsayaer ai ml thorougbred ready run needs jockey ceo circle,0.891951322555542
2020-06-27 10:12:42+00:00,enters downtrend dropped level view odds money news,-1.073905110359192
2020-06-27 05:59:09+00:00,stop discord,-1.031480312347412
2020-06-27 04:21:18+00:00,jul straddle implies move jun pdufa,0.3129135966300964
2020-06-28 23:36:55+00:00,open interest maturity putcallratio,0.91763174533844
2020-06-28 23:28:54+00:00,imagine,0.0205517970025539
2020-06-28 23:12:33+00:00,directional bias report click details,-0.7779198884963989
2020-06-28 23:07:48+00:00,report click,0.2802823483943939
2020-06-28 20:18:18+00:00,collabin buyout announce within spending bil hear logic versus collab royalties,0.7100658416748047
2020-06-28 19:17:30+00:00,understanding thought behind absorb ticker thus driving value ticker pro double theory,0.9489178657531738
2020-06-28 18:02:33+00:00,big pharma name rough rsi macd neg divergences measured move wrong,-1.0812922716140747
2020-06-28 17:59:34+00:00,sounds offering bil notes,0.1279136091470718
2020-06-28 17:46:01+00:00,announce within wait long basically asking obligated sec report money within,0.0252627506852149
2020-06-28 16:48:42+00:00,expected announce earnings,0.3408951163291931
2020-06-28 16:48:36+00:00,expected announce sales billion,0.0937201976776123
2020-06-28 16:44:55+00:00,expected announce earnings,0.3408951163291931
2020-06-28 16:04:45+00:00,wow let start im repeating information announced jun spendi,0.168239414691925
2020-06-28 15:44:06+00:00,actually announced done dd clues lead collab guarantee pretty,0.6030526161193848
2020-06-28 14:59:39+00:00,anything happen filing things promising,0.9804538488388062
2020-06-28 14:46:32+00:00,already known stuff dd correct,0.0264026969671249
2020-06-28 14:44:10+00:00,already buyout,0.9620532989501952
2020-06-28 14:38:40+00:00,part bil form jun divide announce spending approved test neck cancer oh boy,-0.5050922632217407
2020-06-28 14:26:23+00:00,wow let start im repeating information announced jun spending bil companies usually announce nt increase ketruyda sales mention twice,-0.9753296375274658
2020-06-28 09:13:42+00:00,enters downtrend dropped level view odds money news,-1.073905110359192
2020-06-28 05:12:35+00:00,collaborated bought companies anything filing,0.7758340835571289
2020-06-29 23:13:26+00:00,fda oks keytruda treatment patients dmmr metastatic colorectal cancer colorectalcancer cancer,0.0941987037658691
2020-06-29 22:48:00+00:00,woahhhhhhh wording familiar pr tonight breadcrumbs,0.1546850800514221
2020-06-29 22:47:17+00:00,woahhhhhhh wording familiar pr tonight breadcrumbs,0.1326265931129455
2020-06-29 22:34:15+00:00,,0.9571309089660645
2020-06-29 22:27:46+00:00,learn latest fda approval colorectalcancer,0.4239733815193176
2020-06-29 22:07:01+00:00,fda approves keytruda treatment patients dmmr metastatic colorectal,0.2206832468509674
2020-06-29 21:36:59+00:00,fda approves keytruda treatment patients dmmr metastatic colorectal,0.1769594550132751
2020-06-29 21:11:28+00:00,milestone precision medicine fda approves immunotherapy patients dmmr metastatic colorectal cancer,0.2776128947734833
2020-06-29 21:07:01+00:00,ok let sum keytruda approved fda head neck learn colorec,0.9067469835281372
2020-06-29 20:51:42+00:00,fda approves keytruda registered pembrolizumab treatment patients unresectable,0.2080762982368469
2020-06-29 20:35:03+00:00,anothert ah,0.9690687656402588
2020-06-29 20:25:38+00:00,learn latest fda approval colorectalcancer,0.4754774868488312
2020-06-29 20:11:06+00:00,fda oks keytruda highly mutating forms colorectal cancer,-0.0476337224245071
2020-06-29 20:05:12+00:00,huge close hmmm,0.9824858903884888
2020-06-29 19:59:47+00:00,fda oks keytruda highly mutating forms colorectal cancer,-0.533158540725708
2020-06-29 19:57:49+00:00,fda oks keytruda highly mutating forms colorectal cancer,-0.0476337224245071
2020-06-29 19:53:54+00:00,close,0.965298056602478
2020-06-29 19:53:17+00:00,im mad chillin anything profits finna rich,0.8237749338150024
2020-06-29 19:46:44+00:00,filled form planning spend,0.1770362555980682
2020-06-29 19:37:52+00:00,fda approves keytruda therapy certain colorectal cancers,0.0386767014861106
2020-06-29 18:05:35+00:00,shortly received face book family florida freind driving motorcycle alabama hit run received broken jaw find driver,-0.7047772407531738
2020-06-29 17:29:56+00:00,every texting driving sonner later catch someone lose life,-0.061424471437931
2020-06-29 17:20:13+00:00,folks playing lives lives families risk stupit,-0.943629503250122
2020-06-29 17:11:17+00:00,based seen approval events company announce lets roll,0.7833259105682373
2020-06-29 17:00:21+00:00,,0.2911636233329773
2020-06-29 15:50:25+00:00,optimus maximus et opened corp chance avg avg loss avg id stats,0.8739778995513916
2020-06-29 15:01:29+00:00,progress promising,0.9326896667480468
2020-06-29 11:18:55+00:00,uptrend peaks leaves oversold zone view odds,0.946029543876648
2020-06-29 11:16:58+00:00,uptrend peaks leaves oversold zone view odds money news,0.9394015073776244
2020-06-30 23:38:00+00:00,roll blazes segment biomarker trail,0.0913695469498634
2020-06-30 22:33:17+00:00,success rate cancer drug rises success patients reject drug pump tha,0.9141088724136353
2020-06-30 20:24:12+00:00,well considering opposed swap,0.5941741466522217
2020-06-30 19:51:58+00:00,flying,0.9474977254867554
2020-06-30 19:42:46+00:00,keytruda approved early treatment colorectal cancer patients genetic mutations,0.5520312786102295
2020-06-30 19:32:01+00:00,profits sooooooo profits,0.9506072998046876
2020-06-30 19:29:13+00:00,offering saw imo long term pr partnership distribute fda approved medication weak sellers trickle spikes lot,0.800034761428833
2020-06-30 19:15:59+00:00,cancer immunotherapy drug expansion labeling writes cancer immunotherapy,0.5525721311569214
2020-06-30 16:51:08+00:00,whether announcement done later planning dd cat scratch refutes open listening,0.2366696000099182
2020-06-30 16:09:15+00:00,thing locking low rates future home low rates,-0.9947912693023682
2020-06-30 16:03:59+00:00,activity kept pace ended among licensing deals according data,0.0682353004813194
2020-06-30 15:55:45+00:00,already disclosed,0.0440829619765281
2020-06-30 15:54:48+00:00,clue hearing rumor mill billiion disclosed supposed disclose happen amc wait,0.298153668642044
2020-06-30 15:54:27+00:00,fundamental analysis score fa score various fa value score roe roa roic gross margin ebitda etc,0.975943922996521
2020-06-30 14:18:43+00:00,uptrend jump broke lower bollinger band view odds,0.9267996549606324
2020-06-30 14:15:53+00:00,uptrend jump broke lower bollinger band view odds money news,0.9398188591003418
2020-06-30 13:44:30+00:00,optimus maximus et opened corp chance avg avg loss avg id stats,0.8794807195663452
2020-06-30 13:25:56+00:00,icymi keytruda ok line colorectal cancer patients dmmr,0.7940812110900879
2020-06-30 13:01:05+00:00,aproval inprovment keytruda stand along without chemotherapy big deal chemo tars revalation,-0.9399795532226562
2020-06-30 12:25:21+00:00,pre announces fda approves keytruda treatment patients unresectable,0.2492494583129882
2020-06-30 12:25:13+00:00,pre announces fda approves keytruda treatment patients unresectable metastatic dmmr colorectal cancer si,0.1773964762687683
2020-06-30 12:22:45+00:00,pill change course pandemic interview former biotech brain sac capital turned drug developer recently partnered,-0.0935186147689819
2020-06-30 12:02:37+00:00,icymi keytruda ok line colorectal cancer patients dmmr,0.8739172220230103
2020-06-30 11:20:16+00:00,killing mention anything collab,-1.0528253316879272
2020-06-30 09:24:59+00:00,fda approves keytruda registered pembrolizumab treatment patients unresectable metastatic msih dmmr colorectalcancer,0.5045932531356812
2020-06-30 05:21:26+00:00,fda approves keytruda registered treatment patients unresectable metastatic dmmr colorectal cancer,0.1058143228292465
2020-06-30 04:53:15+00:00,sorry misunderstood friend million dollar question research usually pr especially difficult chance collab american company change things,-1.0592399835586548
2020-06-30 03:18:44+00:00,actually deal give equivalent value depending buyout,0.9442451000213624
2020-06-30 03:00:53+00:00,announce collaboration table acquisition bet house happening,-0.2398882955312729
2020-06-30 01:00:24+00:00,fda approves immunotherapy mcc defining standard care,0.321711927652359
2020-07-01 22:34:16+00:00,ridgeback biotherapeutics announce closing collaboration licensing transaction,-0.7396132946014404
2020-07-01 21:59:13+00:00,latest company update,0.2676947712898254
2020-07-01 21:33:01+00:00,ridgeback bio close collaboration licensing transaction msd ridgebackbio,-0.5259056091308594
2020-07-01 21:09:07+00:00,means buyout seems collab news meeting seems issac charge forward long haul,0.9153108596801758
2020-07-01 20:45:06+00:00,ridgeback bio announce closing collaboration licensing transaction,-0.3777269423007965
2020-07-01 20:44:50+00:00,mighty active social media trolling way announced whole different collaboration often collaboration thrown around,0.0298542790114879
2020-07-01 20:35:02+00:00,latest company update,0.2764926254749298
2020-07-01 20:33:20+00:00,ridgeback biotherapeutics close collaboration licensing deal,-0.2207518368959427
2020-07-01 20:21:34+00:00,rising appearances close later avg sd worst later avg sd worst later avg sd worst,-0.1750400215387344
2020-07-01 20:04:29+00:00,optimus maximus et closed covered previously loss corp id stats,-1.0765010118484497
2020-07-01 19:41:40+00:00,way interested saving lives keytruda elements large stables drugs diverse pharma arms diversity dd,1.0049163103103638
2020-07-01 18:24:51+00:00,cancer drug collab waiting pr easily worth,0.819710373878479
2020-07-01 17:46:11+00:00,vallage moving hole village move,0.4573453366756439
2020-07-01 17:39:53+00:00,main asset th history shows succeeded everything trend succees fail ask,0.8521443605422974
2020-07-01 16:49:09+00:00,target,0.9549213647842408
2020-07-01 16:21:40+00:00,shows pps open low close show difference give breath change forward little term history gltall,0.677413821220398
2020-07-01 16:01:18+00:00,vallage moving hole village move,0.4356981813907623
2020-07-01 15:17:49+00:00,thay moved guestion low strick imo,-1.0035167932510376
2020-07-01 15:08:42+00:00,rose dma,0.9150351285934448
2020-07-01 15:06:50+00:00,perhaps poke ahole upward move pps hope showing possitive studys factors moot deep wide,0.8418877124786377
2020-07-01 14:26:35+00:00,,0.9162977933883668
2020-07-01 14:21:02+00:00,humpday blue ribben company volitillity crazy glta,-1.0379375219345093
2020-07-01 13:33:10+00:00,optimus maximus et closed covered previously loss corp id stats,-1.0749027729034424
2020-07-01 11:31:11+00:00,sales earnings conference,-0.0182328186929225
2020-07-01 11:06:49+00:00,us earnings conference edt,0.0131795704364776
2020-07-01 11:02:59+00:00,us earnings conference edt,0.0314072221517562
2020-07-01 10:57:57+00:00,key date approaching msd,-0.0186138078570365
2020-07-01 10:46:22+00:00,sales earnings conference,0.0369831509888172
2020-07-01 10:20:44+00:00,enters uptrend exceeded level view odds money news,0.8999468088150024
2020-07-01 09:29:42+00:00,fda nod keytruda therapy metastatic colorectal cancer patients,0.0262886211276054
2020-07-01 06:09:23+00:00,briefing,0.0051066912710666
2020-07-01 04:50:35+00:00,expected earnings,0.3585638999938965
2020-07-01 04:16:24+00:00,billion sales expected quarter,0.2592760026454925
2020-07-01 04:15:42+00:00,billion sales expected quarter,0.2592760026454925
2020-07-01 01:25:31+00:00,sorry bit confused approval announcement regards public offering closed announcement anything assume partnership,-1.0668928623199463
2020-07-02 23:59:16+00:00,long figure figure company collab pin outcome eli lily study alienated,-1.0278230905532837
2020-07-02 23:02:04+00:00,animal health completes acquisition sentinel registered brand combination parasiticides companion animals,0.2245917618274688
2020-07-02 22:17:12+00:00,guy,0.9420188665390016
2020-07-02 22:09:27+00:00,bar similar efficacy taste alterations,0.537390947341919
2020-07-02 21:40:54+00:00,consistent trend decade hugging cloud closely cl,0.9674930572509766
2020-07-02 21:15:09+00:00,planning,0.2263628393411636
2020-07-02 20:40:46+00:00,ibd ratings,0.0643954575061798
2020-07-02 20:18:06+00:00,consistent trend decade hugging cloud closely cloud fintwit wallstreet,0.9721795320510864
2020-07-02 19:55:03+00:00,fast track king real war mask please,0.9740757942199708
2020-07-02 19:51:00+00:00,fast aprovals load aprovel happen fram charge,0.826033353805542
2020-07-02 19:38:02+00:00,ic main tips qq xps pebb fund tip polar capital global insurance unit trust dyor,0.8726272583007812
2020-07-02 18:56:22+00:00,acquired wendell peter director reported form filed sec,0.1834173798561096
2020-07-02 18:38:36+00:00,keep,0.7969975471496582
2020-07-02 17:18:32+00:00,pharma acquired future dddd,0.174631118774414
2020-07-02 17:04:51+00:00,pharma acquired future dddd,0.354990005493164
2020-07-02 16:51:39+00:00,happy forces vanquish partner,0.9710931777954102
2020-07-02 16:47:23+00:00,insider filing director christine seidman,0.0535541772842407
2020-07-02 16:46:23+00:00,acquired seidman christine director reported form filed sec,0.2091498374938964
2020-07-02 16:44:23+00:00,insider filing director mary ellen coe,0.0507217086851596
2020-07-02 16:36:22+00:00,acquired coe mary ellen director reported form filed sec,0.1773179918527603
2020-07-02 15:58:39+00:00,happy forces vanquish partner,0.9769012928009032
2020-07-02 13:38:51+00:00,village gather,0.5128839015960693
2020-07-02 13:35:42+00:00,derivatives run show imo,0.2529471814632416
2020-07-02 13:26:45+00:00,granted,0.9756523370742798
2020-07-02 12:03:14+00:00,click latest news,0.34400075674057
2020-07-02 10:31:55+00:00,uptrend recovers oversold zone view odds money news,0.9553284645080566
2020-07-02 07:01:22+00:00,animal health completes acquisition sentinel brand,0.1844944655895233
2020-07-02 06:55:53+00:00,dddd exciting reply fda fast tracking approval mrx treat keytruda skipping phase iii main stream application near future transform msd revenue,0.7940812110900879
2020-07-02 06:07:38+00:00,animal health completes acquisition sentinel registered brand combination parasiticides,0.1927799135446548
2020-07-02 06:06:22+00:00,virbac completes divestment sentinel registered brands msd animal health,-0.1138412505388259
2020-07-02 04:30:22+00:00,jul straddle implies move jul jul aids conference aids virtual,0.3167980909347534
2020-07-02 01:04:20+00:00,racist former ceo raymond gilmartin murdered thousands black vioxx stepped position hiding pay visit blacklivesmatter blacklivesmattteruk,-0.2049944251775741
2020-07-03 21:33:34+00:00,fda give ok combining keytruda,0.5855064392089844
2020-07-03 13:05:05+00:00,recent technical crossed dma plus,0.7677408456802368
2020-07-03 11:51:00+00:00,uptrend ascend result broken lower bollinger band view odds money news,0.8645811080932617
2020-07-03 11:14:57+00:00,cantor fitzgerald sets earnings estimates eps,0.0304435715079307
2020-07-03 11:14:07+00:00,research analysts offer predictions earnings,0.046193778514862
2020-07-03 06:44:21+00:00,insider filing director peter wendell,0.0535744428634643
2020-07-04 23:10:20+00:00,oi range expiration putcallratio,0.9654250144958496
2020-07-04 21:31:41+00:00,ridgeback bio announce closing collaboration licensing transaction,-0.7134097814559937
2020-07-04 12:44:33+00:00,upcoming event aids conference aids virtual expiring cover event implied move,0.2267520874738693
2020-07-04 07:23:22+00:00,cacti asset management llc,-0.6375555992126465
2020-07-05 22:07:09+00:00,uptrend expected rise breaks lower bollinger band view odds money news,0.9448394775390624
2020-07-05 06:39:39+00:00,earnings cantor fitzgerald forecasts,0.3258922398090362
2020-07-05 06:24:50+00:00,equities analysts issue forecasts earnings,0.0212747380137443
2020-07-05 04:51:48+00:00,symbol logo mark trademark filing sharp dohme corp,0.0148528292775154
2020-07-06 21:20:26+00:00,ibd ratings,0.0643954575061798
2020-07-06 20:31:31+00:00,innovating hiv remains crucial learn latest data released,0.388184130191803
2020-07-06 19:48:01+00:00,save alot lives hope cancer areas,0.8699774742126465
2020-07-06 19:44:26+00:00,approvals fact moat monetize,0.94249165058136
2020-07-06 17:03:28+00:00,mizuho analyst target,-0.0147067382931709
2020-07-06 16:08:12+00:00,removes competition overhang mizuho securities,-0.205076202750206
2020-07-06 15:23:58+00:00,compounding bad sector increase history repeats self,0.7090959548950195
2020-07-06 15:17:31+00:00,dividend,-0.1413267105817794
2020-07-06 14:56:20+00:00,need brake ice,0.0313511602580547
2020-07-06 14:05:00+00:00,,0.8318237066268921
2020-07-06 12:47:13+00:00,reports analyses showing additional safety efficacy data investigational islatravir,0.1268491894006729
2020-07-06 12:12:48+00:00,announces analyses showing additional safety efficacy data investigational islatravir combination doravirine adults hiv infection,0.1590015441179275
2020-07-06 11:34:14+00:00,bellus health suffers setback clinical failure chronic cough drug writes bayer,-0.876140832901001
2020-07-06 11:33:43+00:00,announces analyses islatravir,0.1792096346616745
2020-07-06 11:26:18+00:00,announces analyses showing additional safety efficacy data investigational islatravir,0.1491259485483169
2020-07-06 11:04:32+00:00,announces analyses showing additional safety efficacy data investigational islatravir combination doravirine adults hiv infection,0.1892591416835785
2020-07-06 11:03:40+00:00,bellus health suffers setback clinical failure chronic cough drug writes bayer shionogi benefit,-0.4335496127605438
2020-07-06 10:58:24+00:00,announces analyses islatravir,0.1761310845613479
2020-07-06 10:47:05+00:00,innovating hiv remains crucial learn latest data released,0.381676435470581
2020-07-06 10:46:21+00:00,announces analyses showing additional safety efficacy data investigational islatravir combinati,0.2347697913646698
2020-07-06 10:46:05+00:00,announces analyses showing additional safety efficacy data investigational islatravir combination doravirine,0.2687781453132629
2020-07-06 09:57:09+00:00,nyse target usa nyse medical,0.1021753102540969
2020-07-06 09:15:29+00:00,uptrend jump broke lower bollinger band view odds money news,0.9398188591003418
2020-07-07 17:17:08+00:00,perhaps brackout foward,-0.0759185478091239
2020-07-07 17:05:19+00:00,pyc physiomics physiomics cited biggest global pharma companies cap,0.0590898022055625
2020-07-07 15:55:03+00:00,flying weather ride enjoy trip,0.9657939672470092
2020-07-07 14:04:20+00:00,undervalued covid play,0.9551770687103271
2020-07-07 13:49:12+00:00,thanks gentalmen give us info outstanding numbers sales happy far,0.9861862659454346
2020-07-07 13:18:44+00:00,moved moving average view odds money news,0.9042935371398926
2020-07-07 12:46:12+00:00,pyc physiomics physiomics cited biggest global pharma companies cap billion published academic research journals,0.0589320883154869
2020-07-07 05:07:11+00:00,dividend pays cash dividend common,0.3399236500263214
2020-07-07 04:03:16+00:00,dividend pays cash dividend common record,0.2797161042690277
2020-07-08 23:38:00+00:00,dangles million flagship foghorn therapeutics drugging shape dna,-0.3998985588550567
2020-07-08 23:28:10+00:00,ibd ratings,0.0643954575061798
2020-07-08 22:43:40+00:00,ceo expects government funding vaccines,0.4249116778373718
2020-07-08 22:00:01+00:00,enters chromatin remodeling space cancer deal foghorn,-0.165361613035202
2020-07-08 21:43:44+00:00,plausible fully compatible upfront akin rounding error,0.0322792269289493
2020-07-08 21:37:30+00:00,heard deal front loaded milestone disclosure bet kept later initial well without pushing valuation,0.9173300266265868
2020-07-08 21:26:41+00:00,pharma industry mostly,0.1202077716588974
2020-07-08 21:00:17+00:00,misread targets came,0.2160689979791641
2020-07-08 20:53:12+00:00,ceo expects government funding vaccines bloomberg,0.5835583209991455
2020-07-08 20:51:07+00:00,announces appointment organon general counsel,0.0238207541406154
2020-07-08 20:41:52+00:00,ceo expects government funding vaccines,0.639814019203186
2020-07-08 20:41:10+00:00,keytruda animal hidden fcf machines cash way wacc money basically guys dcf,0.9861003160476683
2020-07-08 18:33:00+00:00,regulator declined grant speedy approval keytruda lenvima liver cancer citing recent clearance regimen,-0.8900347948074341
2020-07-08 17:04:05+00:00,registered olaparib approved eu germline metastatic pancreatic cancer,0.3900069296360016
2020-07-08 16:54:01+00:00,eisai receive complete response letter keytruda registered pembrolizumab plus lenvima registered lenvatinib combination treatment unresectable hepatocellular carcinoma,0.3293625712394714
2020-07-08 16:41:12+00:00,wait initiated study across us centers ucla yale included,0.974753737449646
2020-07-08 15:04:59+00:00,signs cancer deal foghorn therapeutics,-0.1247595250606536
2020-07-08 14:46:38+00:00,application combination keytruda lenvima treat form liver cancer rejected,-0.9788141250610352
2020-07-08 14:42:57+00:00,recent pancreaticcancer update,-0.035971961915493
2020-07-08 14:15:17+00:00,basket full news paddles shock wake,0.984535813331604
2020-07-08 13:50:44+00:00,rare crl keytruda liver cancer fda ok tecentriq,-0.5937796831130981
2020-07-08 13:41:23+00:00,eisai receive complete response letter keytruda registered pembrolizumab plus lenvima registered lenvatinib,0.3404214680194855
2020-07-08 13:26:25+00:00,bar raised everyone fda bars door star cancer drug roche beat punch,-0.0439818352460861
2020-07-08 12:47:38+00:00,eisai esaly receive complete response letter keytruda pembrolizumab plus lenvima combination,0.3386867046356201
2020-07-08 11:59:26+00:00,pre eisai receive crl keytruda plus lenvima combination treatment unresectable hcc si,-0.4066544473171234
2020-07-08 11:59:21+00:00,pre exclusive eu reaches deals roche supply covid drugs source reuters,-0.4043921530246734
2020-07-08 11:44:55+00:00,eisai receive crl keytruda plus lenvima combination treatment unresectable hepatocellular car,0.2227542698383331
2020-07-08 11:39:01+00:00,crl keytruda,-0.0638666376471519
2020-07-08 11:30:13+00:00,latest oncology news,0.3108176290988922
2020-07-08 11:26:16+00:00,eisai receive crl keytruda plus lenvima combination treatment unresectable hepatocellular carcinoma,0.2874572575092315
2020-07-08 11:25:10+00:00,fda rejects accelerated approval eisai keytruda lenvima combination liver cancer,-0.5862717628479004
2020-07-08 11:22:03+00:00,registered olaparib approved eu germline metastatic pancreatic cancer,0.3900069296360016
2020-07-08 11:21:53+00:00,moved moving average view odds money news,0.9042935371398926
2020-07-08 11:09:59+00:00,full anything happen,0.7049415111541748
2020-07-08 11:07:46+00:00,crl keytruda,-0.0700888782739639
2020-07-08 11:01:27+00:00,eisai fda complete response letter keytruda lenvima treatment unresectable hepatocellular carcinoma msd eisai carcinoma,0.2733173370361328
2020-07-08 10:59:29+00:00,registered approved eu germline metastatic pancreatic cancer,0.2440200746059417
2020-07-08 10:58:00+00:00,recent pancreaticcancer update,-0.0293724797666072
2020-07-08 10:51:49+00:00,eisai receive complete response letter keytruda pembrolizumab plus lenvima lenvatinib combination treatment unresectable hepatocellular carcinoma,0.3509871363639831
2020-07-08 10:49:29+00:00,eisai receive complete response letter keytruda registered plus lenvima registered combination treatment unresectable hepatocellular carcinoma,0.2843680381774902
2020-07-08 10:47:37+00:00,latest oncology news,0.2959749102592468
2020-07-08 10:09:06+00:00,directional bias report click details,-0.7779198884963989
2020-07-08 10:05:57+00:00,report click,0.2802823483943939
2020-07-08 06:19:29+00:00,eu approval pancreatic cancer,0.4004863500595093
2020-07-09 22:33:56+00:00,animal health announces fda approval bravecto chews,0.1009363681077957
2020-07-09 21:12:35+00:00,fda oks animal health chews fleas ticks,-0.0311908051371574
2020-07-09 20:58:02+00:00,amazing oncology division underwhelming dividend opportunity,0.9889703989028932
2020-07-09 20:47:51+00:00,animal health receives fda approval bravecto registered fluralaner chews,0.1466595232486724
2020-07-09 20:46:24+00:00,swinging long,0.2708673775196075
2020-07-09 20:43:50+00:00,animal health receives fda approval bravecto registered fluralaner chews,0.1448948681354522
2020-07-09 20:42:57+00:00,click latest news,0.3487266898155212
2020-07-09 20:35:20+00:00,click latest news,0.34400075674057
2020-07-09 20:33:30+00:00,animal health fda approval bravecto chews,0.4481128454208374
2020-07-09 20:32:27+00:00,animal health fda approval bravecto chews,0.3285722136497497
2020-07-09 17:34:06+00:00,arqule big bought beginning company pursued strategy raising,0.8094543218612671
2020-07-09 17:33:55+00:00,arq cancer mostly blood cancer saw asking fda priority review hematological,-0.3398754894733429
2020-07-09 16:59:02+00:00,cancer startup foghorn deal meds transcription factor target treat broad range cancer patients,0.1419236361980438
2020-07-09 16:30:12+00:00,pr fda grants priority review supplemental biologics license application keytruda registered pembrolizumab,0.0175753682851791
2020-07-09 15:31:46+00:00,deal foghorn ink strategic collaboration cancer million marks foghorn partnership major pharma company cancer,1.004910945892334
2020-07-09 15:23:28+00:00,gives priority review tag keytruda treating certain patients classical hodgkin lymphoma,0.0654253289103508
2020-07-09 14:58:01+00:00,fda grants priority review supplemental biologics license application keytruda registered pembrolizumab treatment patients relapsed refractory classical hodgkin lymphoma,0.0217947512865066
2020-07-09 14:09:57+00:00,amazing oncology division underwhelming dividend opportunity finance,0.9888274669647216
2020-07-09 12:25:36+00:00,max pain maturity,-0.0531261041760444
2020-07-09 11:27:15+00:00,nabs accelerated review keytruda chl,0.0615119412541389
2020-07-09 11:24:24+00:00,fda grants priority review supplemental biologics license application keytruda registered pembrolizumab,0.0588383004069328
2020-07-09 11:09:25+00:00,nabs accelerated review keytruda chl,0.0620414763689041
2020-07-09 11:08:27+00:00,nabs accelerated review keytruda chl,-0.0048439651727676
2020-07-09 11:06:33+00:00,nabs accelerated review keytruda chl,-0.0191910490393638
2020-07-09 10:59:01+00:00,fda grants priority review sbla keytruda,0.0048105306923389
2020-07-09 10:58:07+00:00,fda grants priority review sbla keytruda treatment patients relapsed refractory class,-0.0196543149650096
2020-07-09 10:54:15+00:00,fda grants priority review sbla keytruda treatment patients relapsed refractory classical hodgkin lymphoma pdufa,-0.0199713520705699
2020-07-09 10:51:16+00:00,learn recent bloodcancer update,0.2244220525026321
2020-07-09 10:47:41+00:00,learn recent bloodcancer update,0.1062134653329849
2020-07-09 10:47:27+00:00,fda grants priority review sbla keytruda,0.0202809497714042
2020-07-09 10:30:19+00:00,moved moving average view odds money news,0.9042935371398926
2020-07-09 10:09:46+00:00,eisai receive complete response letter keytruda registered pembrolizumab plus lenvima registered lenvatinib combination treatment unresectable hepatocellularcarcinoma,0.2512507438659668
2020-07-09 10:08:40+00:00,approved eu brcamutated metastatic pancreaticcancer,0.131746232509613
2020-07-09 09:52:21+00:00,foghorn entered collab foghorn proprietary gene traffic control product platform discover,-0.0284761600196361
2020-07-09 09:25:00+00:00,foghorn entered collab foghorn proprietary gene traffic control product platform discover develop oncology assets transcription factor target foghorn receive undisclosed upfront milestones,0.107005089521408
2020-07-09 07:12:25+00:00,interest declines,-1.0636379718780518
2020-07-09 07:09:43+00:00,interest declines,-1.0509878396987915
2020-07-09 01:34:30+00:00,announces appointment organon general counsel,0.0487966164946556
2020-07-09 01:11:31+00:00,haha truly growth portfolio discounts example wacc nuts,1.010918378829956
2020-07-09 01:05:29+00:00,lit shows fact failed bace inhibitor αβ load generated wors,-1.0982829332351685
2020-07-10 19:07:03+00:00,blazes segment biomarker trail colorectal cancer pharma,0.0518920421600341
2020-07-10 18:21:34+00:00,bid ask interest iv diff purchase,0.0048712827265262
2020-07-10 18:13:36+00:00,move news cutting losses,-1.0717140436172483
2020-07-10 18:11:30+00:00,bid ask interest iv diff purchase,0.1463353931903839
2020-07-10 15:04:17+00:00,article sums feel,0.0426213443279266
2020-07-10 13:09:32+00:00,ibd ratings,0.0643954575061798
2020-07-10 13:01:09+00:00,pdufa date calendar,0.1633609384298324
2020-07-10 13:00:11+00:00,pdufa date calendar,0.1376572996377945
2020-07-10 11:43:07+00:00,updated analysis potential collab frame hoped,0.8932391405105591
2020-07-10 11:19:23+00:00,interest declines,-1.0509878396987915
2020-07-10 11:17:58+00:00,interest,-0.9697263240814208
2020-07-10 11:14:53+00:00,interest declines,-1.0509878396987915
2020-07-10 10:44:44+00:00,application clinical prophylactic vaccine entered backlog cta applications france sponsoring themis tmv candidate measle vector,0.2006903737783432
2020-07-10 10:20:58+00:00,fda oks animal health chews fleas ticks,-0.0311908051371574
2020-07-10 09:36:29+00:00,uptrend moving average divergence macd crosses signal line view odds money news,0.9489938020706176
2020-07-10 07:11:22+00:00,forte capital llc adv stake,0.1319351494312286
2020-07-10 03:00:55+00:00,animal health receives fda approval bravecto registered chews,0.1942182183265686
2020-07-10 02:56:36+00:00,animal health receives fda approval bravecto registered chews,0.1444807946681976
2020-07-10 02:16:37+00:00,fda oks animal health chews fleas ticks,-0.030071273446083
2020-07-10 00:56:53+00:00,fda oks bravecto chews dogs puppies age older merckanimalhealth msd msdanimalhealth,0.0314089022576808
2020-07-10 00:00:46+00:00,animal health fda approval bravecto chews,0.1803895086050033
2020-07-11 23:12:42+00:00,fda declines approve eisai liver cancer therapy,-0.7229503393173218
2020-07-11 18:19:43+00:00,discussion bloomberg ceo wan na asset hit possible exceptionally ethical company,0.9806350469589232
2020-07-11 15:57:42+00:00,fda grants priority review supplemental biologics license application keytruda registered treatment pa,-0.0265731066465377
2020-07-11 11:06:09+00:00,technical cup handle dma resistance,-0.2713370025157928
2020-07-11 09:37:11+00:00,technical cup handle dma resistance,-0.1881423890590667
2020-07-11 09:37:05+00:00,enters uptrend exceeded level view odds money news,0.8955531120300293
2020-07-11 09:05:44+00:00,interest drops,-1.0218045711517334
2020-07-11 08:59:15+00:00,interest drops,-1.0218045711517334
2020-07-12 20:11:11+00:00,ibd ratings,0.0643954575061798
2020-07-12 09:13:49+00:00,enters uptrend exceeded level view odds money news,0.8999468088150024
2020-07-12 07:11:07+00:00,vigilant capital management llc,-0.6313828229904175
2020-07-13 20:19:00+00:00,crazy science signs partner hunt hiv cure,-0.9570531845092772
2020-07-13 18:04:44+00:00,village tribsman raise pps well darivatives wide lift,0.9465959072113036
2020-07-13 16:11:01+00:00,imo areas need virus easy cancer unmet treatments heath needs important well,0.9401566982269288
2020-07-13 15:54:32+00:00,kicking earnings thur change dynamicks health segment large amount directed goverment sectore raise bar,0.1929899007081985
2020-07-13 15:20:27+00:00,collaberat together shot lead movement including big pharmas thoughts glta,0.8163506984710693
2020-07-13 15:07:58+00:00,big players big winners life saving treatments imo,0.9925264120101928
2020-07-13 15:07:56+00:00,sector move across board realize beat important shine big players funding bios,0.8080834150314331
2020-07-13 14:35:13+00:00,moderating discussion cancer drug development prior panel hear fda rick pazdur johns hopkins elizabeth jaffee eric rubin,-0.0706865713000297
2020-07-13 12:44:00+00:00,phase study gefapixant mk adult participants chronic cough mk nct estimated primary completion date,-0.1637202650308609
2020-07-13 12:43:02+00:00,phase evaluation safety tolerability immunogenicity varivax healthy russians nct estimated primary completion date,0.874871015548706
2020-07-13 12:42:03+00:00,phase pembrolizumab untreated extensive sclc nct estimated primary completion date,-0.012489728629589
2020-07-13 12:41:04+00:00,phase phase study combination capecitabine radiotherapy rectal cancer nct estimated primary completion date,-8.555874228477478e-05
2020-07-13 12:40:05+00:00,phase orodispersible tablets odt schistosoma infected children nct estimated primary completion date,-0.1054522171616554
2020-07-13 09:49:52+00:00,enters uptrend exceeded level view odds money news,0.8999468088150024
2020-07-13 05:27:56+00:00,failed ccam dosage miss decided stop clinical development mk kn,-1.086559176445007
2020-07-13 01:32:03+00:00,partnershup cap close million,0.5237104892730713
2020-07-13 00:51:59+00:00,partnershup cap close million prime position insitutuonal insider alone telll parabolic,0.9644126892089844
2020-07-14 23:56:04+00:00,phase phase mk gemcitabine cell lung cancer nsclc nct estimated primary completion date,-0.1229215711355209
2020-07-14 23:55:07+00:00,phase randomized phase ii study eribulin mesylate without pembrolizumab metastatic hormone receptor positive breast cancer nct estimated primary completion date,0.5571764707565308
2020-07-14 23:54:09+00:00,phase phase blinatumomab pembrolizumab adults relapsed refractory acute lymphoblastic leukemia marrow lymphoblasts nct estimated primary completion date,0.1634007543325424
2020-07-14 23:53:11+00:00,phase phase pembrolizumab idelalisib lung cancer study nct estimated primary completion date,-0.0559168346226215
2020-07-14 23:52:13+00:00,phase grapiprant pembrolizumab patients advanced progressive mss colorectal cancer nct estimated primary completion date,0.4094700515270233
2020-07-14 23:51:15+00:00,phase phase safety tolerability pembrolizumab mk pegylated interferon alfa pembrolizumab ipilimumab participants advanced melanoma renal cell carcinoma mk keynote nct estimated primary completion date,0.2802696526050567
2020-07-14 23:50:17+00:00,phase pharmacokinetics study mk pediatric participants infections mk nct estimated primary completion date,-0.2046203315258026
2020-07-14 23:49:20+00:00,phase safety efficacy pembrolizumab mk combination ts cisplatin ts oxaliplatin line chemotherapy gastric cancer mk keynote nct estimated primary completion date,0.3949871957302093
2020-07-14 20:56:17+00:00,ceo raising covid vaccine hopes grave disservice report href,-1.0092467069625854
2020-07-14 20:21:22+00:00,rising appearances close later avg sd worst later avg sd worst later avg sd worst,-0.1785763204097747
2020-07-14 19:40:32+00:00,receives consensus rating analysts,0.8333829641342163
2020-07-14 19:38:25+00:00,receives consensus rating analysts,0.8333829641342163
2020-07-14 19:25:40+00:00,dma,0.881486177444458
2020-07-14 18:52:53+00:00,,0.6672643423080444
2020-07-14 18:39:23+00:00,expiration open interest open interest,0.9279537200927734
2020-07-14 17:06:57+00:00,flow update optionsflow healthcare,0.7472858428955078
2020-07-14 16:03:56+00:00,hackensack meridian cdi announce covid research collaboration,0.0252648741006851
2020-07-14 15:56:11+00:00,kenneth frazier ultimately vaccine billions,0.0559086501598358
2020-07-14 15:46:57+00:00,kenneth frazier ultimately vaccine billions vaccine vaccines pharma biotech,0.161972627043724
2020-07-14 13:18:35+00:00,itronics itro provides update auric fulstone polymetallic gold exploration project,0.1552860289812088
2020-07-14 12:39:48+00:00,ibd ratings,0.0643954575061798
2020-07-14 12:13:54+00:00,moving average broke moving average view odds money news,0.8901073932647705
2020-07-15 22:41:14+00:00,ceo ken frazier speak commit broad equitable affordable access matter,0.5526634454727173
2020-07-15 21:58:25+00:00,ceo ken frazier speak complacent status quo complicit racism status quo generates leadership management money,-0.827491044998169
2020-07-15 21:56:19+00:00,ceo ken frazier speak let society enough subtle messages young africanamericans measure psychological armor defend oneself racism around leadership management money,-0.7908580303192139
2020-07-15 21:49:19+00:00,ceo ken frazier speak let society enough subtle messages young africanamericans measure psychological armor defend oneself racism around leadership management money,-0.7908580303192139
2020-07-15 21:45:25+00:00,ceo ken frazier speak complacent status quo complicit racism status quo generates leadership management money,-0.7274576425552368
2020-07-15 15:22:53+00:00,pivotal ph iii study antiviral letermovir met primary endpoint cytomegalovirus,0.0125753805041313
2020-07-15 15:13:43+00:00,realize pr covid companies longs general public,-0.072677195072174
2020-07-15 14:36:39+00:00,interesting pretty definite valent pneumococcal vaccine,0.9376838207244872
2020-07-15 14:03:27+00:00,hit line second,0.1889620572328567
2020-07-15 13:46:55+00:00,ceo talk vaccine earth dump,-1.047502875328064
2020-07-15 13:16:34+00:00,ibd ratings,0.0643954575061798
2020-07-15 13:12:20+00:00,ceo talk vaccine earth dump,-1.0605716705322266
2020-07-15 12:58:13+00:00,ceo terms ceo raising covid vaccine hopes grave disservi,-0.115695983171463
2020-07-15 10:20:51+00:00,moved moving average view odds money news,0.904301643371582
2020-07-15 09:30:34+00:00,ceo terms ceo raising covid vaccine hopes grave disservice report,-0.2952554523944855
2020-07-15 02:46:19+00:00,ceo raising covid vaccine hopes grave disservice report,-0.8999133110046387
2020-07-15 02:42:45+00:00,early yes ph agree ceo fail stop hopes tell truth set realistic timelines expectations beat hell goals despise method overpromising setting mkt fail,-1.0285329818725586
2020-07-15 02:06:21+00:00,receives consensus rating analysts,0.8614242076873779
2020-07-15 02:01:29+00:00,phase phase mk gemcitabine cell lung cancer nsclc nct estimated primary completio,-0.0659948289394378
2020-07-15 01:33:12+00:00,ceo implying cases,-0.3094272911548614
2020-07-15 00:51:13+00:00,ceo implying cases,-0.2179615199565887
2020-07-16 19:31:23+00:00,either news,0.9713643789291382
2020-07-16 19:26:14+00:00,oi range expiration putcallratio,0.9676101207733154
2020-07-16 18:47:07+00:00,expiration open interest open interest,0.92890465259552
2020-07-16 16:30:31+00:00,keytruda set drug worldwide bn sales forecast almost double closest rival download copy evaluatepharma world preview find oncology,0.6671338081359863
2020-07-16 14:25:12+00:00,recent technical cup handle plus,0.4000898599624634
2020-07-16 12:24:13+00:00,fda grants priority review drug application vericiguat,0.1225637346506118
2020-07-16 11:35:52+00:00,oncorus announces clinical collaboration evaluate combination oncorus oncr keytruda registered pembrolizumab,0.0143978409469127
2020-07-16 11:29:40+00:00,fda grants priority review nda vericiguat pdufa,0.0496768169105052
2020-07-16 11:12:29+00:00,exercises license preclinical program collaboration,0.2470627427101135
2020-07-16 11:09:29+00:00,announces clinical collaboration agreement oncorus oncr,-0.0026245787739753
2020-07-16 10:59:59+00:00,fda grants priority review drug application vericiguat,0.1225637346506118
2020-07-16 10:59:35+00:00,fda accepts application heart drug vericiguat accelerated review,0.0451072007417678
2020-07-16 10:56:52+00:00,fda accepts application heart drug vericiguat accelerated review,0.0168371610343456
2020-07-16 10:47:00+00:00,fda grants priority review nda vericiguat pdufa,0.0756410956382751
2020-07-16 10:46:49+00:00,researching paths forward heartfailure learn latest cardiovascular update,0.0177982896566391
2020-07-16 10:46:13+00:00,delayed issued press release application based contemporary outcomes study focused exclusively chronic heart failure patient population worsening event,-0.5487369298934937
2020-07-16 09:26:19+00:00,moving average crossed moving average view odds money news,0.8948520421981812
2020-07-16 07:01:55+00:00,signed cooperation agreement,0.0874876379966735
2020-07-16 06:49:26+00:00,patient propecia clinical suffered permanent sexual dysfunction discontinuing finasteride,-0.7910842895507812
2020-07-16 03:11:38+00:00,thing course drug timeline process focus main drugs hepitatis influenza corona virus inhibitors let start collab,-0.9511816501617432
2020-07-16 01:47:07+00:00,doj dismantle death cult known killed thousands arrestkenfrazier propecia justiceforvioxxvictims,-0.9087749719619752
